{"gene":"LCN2","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1993,"finding":"LCN2 (NGAL) was isolated as a 25-kDa protein physically associated with human neutrophil gelatinase (MMP-9); immunoprecipitation and immunoblotting demonstrated that the 135-kDa form of gelatinase is a complex of 92-kDa gelatinase and NGAL, while the 220-kDa form is a homodimer of gelatinase alone. NGAL was identified as a member of the lipocalin family with one N-glycosylation site.","method":"Immunoprecipitation, immunoblotting, protein purification, primary structure determination, N-glycanase treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — original isolation with multiple orthogonal biochemical methods; foundational paper with 978 citations","pmids":["7683678"],"is_preprint":false},{"year":1991,"finding":"Mouse 24p3 protein (Lcn2) was identified as a member of the lipocalin protein family based on three conserved sequence motifs, proposing a ligand-binding function for small hydrophobic molecules.","method":"Computational sequence analysis using conserved lipocalin motifs","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 4 — computational prediction only","pmids":["1834059"],"is_preprint":false},{"year":1997,"finding":"The human NGAL gene was cloned and sequenced (5869 bp including 1695 bp of 5′ non-transcribed region, seven exons, six introns); transcriptional start sites were identified by RNase protection assay; the promoter contains binding sites for NF-κB, GATA-1, PU.1, and CTF/CBP, consistent with regulation in neutrophils and epithelial cells exposed to microorganisms.","method":"Gene cloning, sequencing, RNase protection assay, promoter analysis","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 — direct cloning and transcriptional start site mapping with multiple methods","pmids":["9339356"],"is_preprint":false},{"year":2001,"finding":"LCN2 (24p3) is transcriptionally induced after IL-3 withdrawal in hematopoietic cells; conditioned medium containing secreted 24p3 induces apoptosis in naive IL-3-replete FL5.12 cells via an autocrine pathway; apoptotic sensitivity correlates with presence of a cell-surface receptor for 24p3; 24p3 induces apoptosis across a wide variety of leukocytes but not non-hematopoietic cells.","method":"DNA microarray, conditioned medium transfer, apoptosis assays, receptor-binding correlation","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (microarray, conditioned medium, receptor correlation); 311 citations; foundational mechanism paper","pmids":["11486081"],"is_preprint":false},{"year":2005,"finding":"Megalin (LRP2), a member of the LDL receptor family expressed in polarized epithelia, binds NGAL with high affinity (demonstrated by surface plasmon resonance) and mediates its endocytosis in a megalin-antibody-blockable manner in rat yolk sac cells.","method":"Surface plasmon resonance, antibody-blocking endocytosis assay in BN16 cells","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1–2 — direct binding measurement plus functional cellular uptake assay; 283 citations","pmids":["15670845"],"is_preprint":false},{"year":2005,"finding":"Ngal (LCN2) forms a complex with iron-binding siderophores (Ngal:siderophore:Fe) that is endocytosed by renal proximal tubule cells; this complex upregulates heme oxygenase-1, preserves N-cadherin, and inhibits cell death, protecting the kidney from ischemia-reperfusion injury; iron delivery is required since gallium (siderophore blockade) abolishes rescue; mouse urine contains an endogenous Ngal-dependent siderophore-like activity.","method":"Mouse ischemia-reperfusion model, single-dose protein rescue, gallium blockade, immunohistochemistry, in vivo iron delivery assay","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo rescue with mechanistic dissection (iron requirement, HO-1 induction, N-cadherin preservation); 756 citations","pmids":["15711640"],"is_preprint":false},{"year":2005,"finding":"The 24p3 receptor (24p3R) internalizes iron-bound 24p3 to prevent apoptosis by delivering iron to cells, whereas the apo (iron-free) form of 24p3 induces cellular iron efflux and apoptosis through upregulation of the pro-apoptotic protein Bim.","method":"Receptor identification, iron-loaded vs. apo-protein internalization assays, Bim induction measurement","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — mechanistic dissection of receptor-mediated iron delivery vs. efflux; published in Cell; referenced in multiple independent papers","pmids":["16377555"],"is_preprint":false},{"year":2007,"finding":"NGAL exerts bacteriostatic effects by capturing siderophores and depleting them of iron; eukaryotic siderophore-like molecules can bind NGAL to shuttle iron between extracellular and intracellular spaces; NGAL deficiency in mice leads to increased bacterial growth; NGAL acts as a growth and differentiation factor in renal epithelia, with activity enhanced by siderophore:iron complexes.","method":"NGAL-deficient mouse model (bacterial growth studies), cell culture differentiation assays, siderophore-binding assays","journal":"Journal of the American Society of Nephrology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO plus in vitro assays; comprehensive review synthesizing multiple experimental lines; 596 citations","pmids":["17229907"],"is_preprint":false},{"year":2007,"finding":"LPS-induced endotoxemia increases 24p3/Lcn2 expression in mouse lung and liver within 4 h via TLR-4 signaling; cells from C3H/HeJ mice with a nonfunctional TLR-4 show minimal 24p3 induction; NF-κB nuclear binding activity increases in alveolar macrophages and Type II cells; C/EBP activation occurs only in Type II cells, indicating differential transcription factor usage.","method":"In vivo LPS administration, RT-PCR, Western blot, immunohistochemistry, TLR-4 mutant mice, NF-κB and C/EBP EMSA","journal":"Experimental and molecular pathology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic model (TLR-4 mutant) plus transcription factor assays; single study","pmids":["17490638"],"is_preprint":false},{"year":2008,"finding":"24p3 is a direct transcriptional target of Foxo3a; PI3K/Akt (but not MAPK) mediates IL-3-repressed 24p3 expression by phosphorylating and inactivating Foxo3a; constitutively active Akt attenuates 24p3 expression and apoptosis after IL-3 withdrawal; Foxo3a binds directly to the 24p3 promoter and induces its activity.","method":"Promoter reporter assay, ChIP (Foxo3a binding to 24p3 promoter), constitutively active Akt overexpression, PI3K/MAPK inhibitors, FL5.12 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — direct promoter binding (ChIP), epistasis with constitutively active Akt, multiple inhibitor approaches","pmids":["19056725"],"is_preprint":false},{"year":2009,"finding":"BCR-ABL upregulates 24p3 expression via the JAK/STAT pathway (Stat5 binds the 24p3 promoter), while simultaneously repressing 24p3R expression by switching Runx3 (activator) to Runx1 (repressor) binding through a Ras signaling pathway; this asymmetry allows BCR-ABL+ cells to secrete apoptosis-inducing 24p3 that kills normal cells expressing 24p3R but not BCR-ABL+ cells themselves; repression of 24p3R is required for imatinib to kill BCR-ABL+ cells.","method":"ChIP (Stat5 binding to 24p3 promoter; Runx1/3 binding to 24p3R promoter), signaling pathway inhibitors, imatinib kill assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP with mechanistic epistasis across two pathways; functional consequence in drug sensitivity validated","pmids":["19229297"],"is_preprint":false},{"year":2006,"finding":"IL-17 induces 24p3/lipocalin-2 transcription primarily through two essential promoter elements: NF-κB and C/EBP binding sites; deletion of either site eliminates promoter activity; IL-17 synergizes with TNF-α at the promoter level. NF-κB and C/EBP sites are statistically over-represented in IL-17 target gene promoters.","method":"Promoter deletion/reporter assays, TFBS computational analysis across 18 IL-17 target genes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — promoter deletion mapping with functional validation plus bioinformatics confirmation; 250 citations","pmids":["16798734"],"is_preprint":false},{"year":2009,"finding":"Lcn2 promotes breast cancer epithelial-to-mesenchymal transition (EMT) by upregulating mesenchymal markers (vimentin, fibronectin), downregulating E-cadherin, and increasing cell motility and invasiveness; this occurs through suppression of ERα and induction of the EMT transcription factor Slug; ERα overexpression reverses Lcn2-induced EMT; in orthotopic models, Lcn2-expressing tumors show increased local invasion and lymph node metastasis.","method":"Lcn2 overexpression/silencing in breast cancer cells, EMT marker immunoblotting, motility/invasion assays, ERα rescue, orthotopic mouse model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function and loss-of-function with defined molecular pathway (ERα/Slug axis) and in vivo validation; 309 citations","pmids":["19237579"],"is_preprint":false},{"year":2010,"finding":"Lcn2 is an active driver of chronic kidney disease (CKD) progression: Lcn2-/- mice show dramatically reduced renal lesion severity after nephron reduction; Lcn2 expression is induced by EGFR activation; HIF-1α is required for EGFR-induced Lcn2 overexpression; Lcn2 mediates the mitogenic effect of EGFR during renal deterioration (cell proliferation markedly reduced in Lcn2-/- mice); EGFR inhibition prevents Lcn2 upregulation.","method":"Lcn2 knockout mice (nephron reduction model), EGFR dominant-negative transgenic mice, HIF-1α requirement assessed, genome-wide expression profiling, EGFR inhibitor treatment","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with mechanistic epistasis (EGFR→HIF-1α→Lcn2 pathway), multiple genetic and pharmacological approaches; 320 citations","pmids":["20921623"],"is_preprint":false},{"year":2011,"finding":"24p3-null mice accumulate lymphoid, myeloid, and erythroid cells due to apoptotic defects in mature hematopoietic cell types (neutrophils, mast cells, thymocytes, erythroid cells); Bim induction in response to apoptotic stimuli is attenuated in 24p3-/- cells, explaining their resistance to cell death; competitive repopulation shows no enhanced hematopoiesis, confirming a survival rather than proliferation defect.","method":"24p3 null mice (C57BL/6 and 129/SVE backgrounds), competitive repopulation, myelosuppression recovery, apoptosis assays, Bim Western blotting, dexamethasone-induced thymocyte apoptosis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic KO with defined molecular effector (Bim) across multiple hematopoietic lineages","pmids":["21507940"],"is_preprint":false},{"year":2012,"finding":"S2R(Pgrmc1) regulates NGAL/LCN2 expression at the mRNA and protein levels; S2R knockdown decreases MMP-9 activity, and NGAL is required for MMP-9 activity and tumor formation; S2R associates with EGFR to increase EGFR membrane levels, and EGFR/Akt/ERK inhibitors suppress NGAL expression; LCN2 is transcriptionally regulated by NF-κB, and S2R knockdown reduces p65/RelA acetylation and phosphorylation; HDAC1 inhibitors restore p65 acetylation and partially restore NGAL levels.","method":"Antibody array screening, siRNA knockdown, RT-PCR, Western blot, gelatin zymography, EGFR/Akt/ERK inhibitors, NF-κB activation assays, HDAC inhibitors","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple inhibitor approaches and knockdown with pathway placement; single study","pmids":["22418433"],"is_preprint":false},{"year":2013,"finding":"24p3-deficient neutrophils are defective in extravasation to infection sites, chemotaxis, and phagocytosis of bacteria; transcriptome analysis shows selective suppression of genes controlling cytoskeletal reorganization, and microRNAs regulating upstream cytoskeletal proteins are increased in 24p3-/- neutrophils; 24p3-/- mice show enhanced susceptibility to Listeria, Candida, and Staphylococcus, which is not attributable to siderophore sequestration.","method":"24p3-/- mice, in vivo infection models, neutrophil chemotaxis assays, phagocytosis assays, transcriptome analysis, microRNA profiling","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple cellular functional readouts and transcriptomic mechanism; non-siderophore mechanism established","pmids":["23543755"],"is_preprint":false},{"year":2013,"finding":"The 24p3 receptor (24p3R/SLC22A17) mediates albumin endocytosis in cortical collecting duct cells and activates NF-κB and TGF-β1 signaling in response to luminal albumin, leading to upregulation of profibrotic markers (Snail, vimentin) via an autocrine mechanism.","method":"FITC-albumin uptake assay, NF-κB luciferase reporter, NF-κB p65 nuclear translocation, target gene expression, 24p3R siRNA knockdown in mCCDcl1 cells, in vivo PAN nephrotic rat model","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor knockdown with defined signaling readouts; in vitro and in vivo correlation","pmids":["23884139"],"is_preprint":false},{"year":2014,"finding":"LCN2 regulates hepatic lipid droplet formation by controlling expression of the lipid droplet coat protein PLIN5 (Perilipin 5/OXPAT); Lcn2-/- mice fed MCD diet accumulate more hepatic lipids with reduced basal PLIN5; restoration of LCN2 in Lcn2-/- primary hepatocytes by transfection or adenoviral infection restores PLIN5 expression and proper lipid droplet formation.","method":"Lcn2-/- mice, MCD and high-fat diet models, adenoviral LCN2 reconstitution, PLIN5 Western blot and IHC, lipid accumulation quantification in vitro and in vivo","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — genetic KO plus reconstitution (adenoviral) with defined molecular target (PLIN5)","pmids":["25086218"],"is_preprint":false},{"year":2017,"finding":"Glucocorticoids and mineralocorticoids synergize with IL-1 to induce LCN2 expression in chondrogenic cells; this effect requires glucocorticoid or mineralocorticoid receptors and is mediated through PI3K, ERK1/2, and JAK2 kinases.","method":"ATDC5 chondrogenic cell line, RT-qPCR, Western blot, signaling pathway inhibitors (PI3K, ERK1/2, JAK2), corticoid receptor antagonists","journal":"Osteoarthritis and cartilage","confidence":"Medium","confidence_rationale":"Tier 2 — multiple inhibitors defining pathway; single study, single cell line","pmids":["28185846"],"is_preprint":false},{"year":2017,"finding":"LCN2 attenuates autophagy to exacerbate cardiac apoptosis during ischemia: Lcn2-KO mice show greater ischemia-induced autophagy (LC3/p62 Western blot, LC3 IHC, TEM) and are protected from ischemia-induced caspase-3 activation and cardiac dysfunction; exogenous Lcn2 treatment of cardiomyocytes suppresses autophagic flux (AMPK/ULK1 phosphorylation, tandem RFP/GFP-LC3, cathepsin activity), and exacerbates hypoxia-induced cytochrome c release and caspase-3 activation; autophagy-deficient (dominant-negative Atg5) cells show increased apoptosis with Lcn2 treatment.","method":"Lcn2-KO mice (coronary ligation), echocardiography, Western blot (LC3, p62, AMPK, ULK1), TEM, tandem fluorescent LC3 assay, lysosomal cathepsin assay, DN-Atg5 overexpression","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO plus gain-of-function with multiple orthogonal autophagy readouts and defined epistasis with Atg5","pmids":["27800610"],"is_preprint":false},{"year":2018,"finding":"Tumor-associated macrophages (TAMs) secrete LCN2 to deliver iron to tumor cells; LCN2-neutralizing antibody restores intracellular iron to pre-TAM levels, establishing LCN2 as an iron transporter between macrophages and tumor cells in the microenvironment.","method":"TAM co-culture, LCN2 ELISA, intracellular iron measurement, LCN2-neutralizing antibody, tumor cell iron assays","journal":"International journal of physiology, pathophysiology and pharmacology","confidence":"Medium","confidence_rationale":"Tier 3 — single-lab study with antibody neutralization; iron transport function demonstrated functionally","pmids":["29755643"],"is_preprint":false},{"year":2021,"finding":"Loss of LIFR in hepatocytes activates NF-κB signaling through SHP1, leading to upregulation of LCN2; LCN2 sequesters iron and confers resistance to ferroptosis inducers; an LCN2-neutralizing antibody enhances ferroptosis-inducing and anticancer effects of sorafenib on HCC patient-derived xenograft tumors with low LIFR/high LCN2.","method":"Hepatocyte-specific and inducible Lifr-KO mice, NF-κB pathway analysis, LCN2 expression measurement, ferroptosis assays (lipid peroxidation, cell death), LCN2-neutralizing antibody in PDX tumor model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with mechanistic pathway (LIFR→SHP1→NF-κB→LCN2→ferroptosis resistance) and therapeutic validation in PDX","pmids":["34921145"],"is_preprint":false},{"year":2022,"finding":"NOX (NADPH oxidase)-NF-κB signaling in reactive astrocytes drives LCN2 expression and secretion after stroke; astrocyte-specific NHE1 deletion reduces astrogliosis and LCN2/GFAP expression, decreasing neuronal loss; ischemia triggers LCN2-containing exosome secretion from astrocytes that causes neuronal death; NHE1 inhibitor (HOE642) reduces LCN2+ exosome secretion; LCN2-mediated neuronal apoptosis and neurite degeneration are attenuated by NHE1 inhibition.","method":"Astrocyte-specific Nhe1 conditional KO mice (stroke model), in vitro ischemia in astrocyte cultures, exosome isolation and characterization, Western blot, NOX/NF-κB inhibitors, neuronal viability assays","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 — genetic astrocyte-specific KO with mechanistic pathway (NHE1→NOX→NF-κB→LCN2) and functional neuronal death readout","pmids":["35440572"],"is_preprint":false},{"year":2022,"finding":"Glioma-derived exosomes upregulate LCN2 in brain microvascular endothelial cells via the JAK-STAT3 pathway (LCN2 is not delivered from exosomes but induced in recipient cells); LCN2 upregulation increases membrane fluidity of endothelial cells, facilitating nanocapsule crossing of the blood-brain barrier; LCN2 knockdown in endothelial cells abrogates the exosome-induced membrane fluidity effect.","method":"Tandem mass tag proteomics, JAK-STAT3 pathway inhibitors, LCN2 siRNA knockdown, membrane fluidity assay, in vivo nanocapsule BBB crossing (IP and IV injection)","journal":"Journal of controlled release","confidence":"Medium","confidence_rationale":"Tier 2 — proteomics plus siRNA knockdown with defined pathway and functional BBB permeability readout; single study","pmids":["35341902"],"is_preprint":false},{"year":2023,"finding":"LCN2 secretion from reactive astrocytes can be reduced by two mechanisms: (1) proteasome inhibition suppresses NF-κB activation through IκBα stabilization, downregulating Lcn2 expression; (2) autophagic flux activation via mTOR inhibition degrades intracellular LCN2 pre-secretorily; the N-terminal signal peptide of LCN2 is critical for both its secretion and pre-secretory autophagic degradation; reducing secreted LCN2 by either mechanism increases neuronal viability under inflammatory stress.","method":"LPS-stimulated primary astrocytes, proteasome inhibitor (bortezomib), mTOR inhibitor, IκBα Western blot, autophagy flux assays (LC3/SQSTM1), LCN2 signal peptide deletion mutants, neuronal viability assays in conditioned medium","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 1–2 — two mechanistically distinct pathways both validated with defined molecular intermediates and functional neuronal readout","pmids":["36781380"],"is_preprint":false},{"year":2023,"finding":"Tissue-infiltrating neutrophils (TI-Neu) are the primary source of LCN2 in lung cancer cachexia; LCN2 secreted by TI-Neu induces ferroptosis in adipose and muscle tissues, causing wasting; antibody depletion of TI-Neu and myeloid-specific Lcn2 knockout both prevent ferroptosis and tissue wasting; chemical inhibition of ferroptosis alleviates tissue wasting and prolongs survival.","method":"Lung cancer mouse models, LCN2 blockade/overexpression, antibody depletion of neutrophils, myeloid-specific Lcn2 KO (LysM-Cre), ferroptosis inhibitor (ferrostatin), tissue iron/lipid peroxidation assays","journal":"Journal of hematology & oncology","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO plus antibody depletion defining LCN2 source; ferroptosis mechanism validated pharmacologically","pmids":["36973755"],"is_preprint":false},{"year":2023,"finding":"LCN2 binds SLC3A2 (system Xc- heavy chain) and inhibits downstream glutathione synthesis and GPX4 expression, promoting ferroptosis after intracerebral hemorrhage; this interaction was validated by molecular docking and co-immunoprecipitation.","method":"Co-immunoprecipitation, molecular docking, proteomics, LCN2 overexpression/rescue experiments, GSH and GPX4 measurement in brain tissue","journal":"Phytomedicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — co-IP binding plus functional ferroptosis readout; single study with pharmacological intervention","pmids":["37130481"],"is_preprint":false},{"year":2023,"finding":"LCN2 binds EGFR and enhances EGFR recycling back to the plasma membrane, thereby activating the EGFR-MEK-ERK cascade in oral squamous cell carcinoma; LCN2 inhibition reduces EGFR phosphorylation and downstream signaling, suppressing proliferation and metastasis.","method":"Mass spectrometry, co-IP, immunoblotting, immunofluorescence, EGFR recycling assays, siRNA knockdown, in vivo xenograft and PDX models","journal":"Journal of experimental & clinical cancer research","confidence":"High","confidence_rationale":"Tier 2 — MS-identified interaction validated by co-IP, receptor recycling mechanistically demonstrated, and rescued in vivo","pmids":["36899380"],"is_preprint":false},{"year":2023,"finding":"Increased LCN2 in reactive astrocytes suppresses neurogenesis; anti-neurogenic effects of LCN2 are mediated by SLC22A17 (24p3R); Ngfr expression reduces reactive astrocyte LCN2, and SLC22A17 blockade recapitulates the pro-neurogenic effect; LCN2/SLC22A17 axis downstream of NGFR signaling modulates astrocyte fate in Alzheimer's disease.","method":"APP/PS1dE9 mouse model, AAV-Ngfr hippocampal injection, single-cell transcriptomics, spatial proteomics, SLC22A17 functional knockdown, neurogenesis histology, 3D human astroglial cultures","journal":"NPJ Regenerative medicine","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic manipulation with single-cell transcriptomics; SLC22A17 knockdown epistasis; single study","pmids":["37429840"],"is_preprint":false},{"year":2023,"finding":"LCN2 forms a ternary complex with LOXL2 and MMP9; LCN2-LOXL2 and LCN2-MMP9 interactions occur both intracellularly and extracellularly, while LOXL2-MMP9 interaction is only intracellular; the LCN2/LOXL2/MMP9 complex promotes ECM degradation (fibronectin, Matrigel), filopodia formation, microfilament rearrangement via profilin-1 upregulation, and activates FAK/AKT/GSK3β signaling to drive ESCC metastasis.","method":"Co-IP (protein-protein interaction assays), co-overexpression, ECM degradation assays, filopodia/actin imaging, SPOCK1 and FAK/AKT/GSK3β pathway Western blots, in vivo tumor growth and metastasis","journal":"Molecular oncology","confidence":"Medium","confidence_rationale":"Tier 2–3 — co-IP defines trimeric complex with intracellular/extracellular localization distinction; downstream pathway and functional assays; single study","pmids":["37753805"],"is_preprint":false},{"year":2024,"finding":"MafG physically interacts with MYH9 (non-muscle myosin heavy chain IIa) and the MafG/MYH9 complex transcriptionally activates LCN2 via a MARE motif in the LCN2 promoter; site-directed mutation of the MARE motif blocks MafG binding and LCN2 transcription; LCN2 re-expression in MafG-knockdown HSCs restores resistance to ferroptosis, thereby promoting liver fibrosis.","method":"Co-IP (MafG-MYH9 interaction), MARE motif site-directed mutagenesis, LCN2 promoter reporter assay, LCN2 reconstitution in MafG-KD cells, BDL mouse model, AAV6 HSC-specific MafG knockdown, ferroptosis assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1–2 — protein interaction (co-IP), promoter mutagenesis, reconstitution rescue, and in vivo genetic validation","pmids":["38871948"],"is_preprint":false},{"year":2024,"finding":"BDH1 overexpression reprograms ketone metabolism, increasing AcAc and decreasing β-OHB, which reduces β-hydroxybutyrylation of H3K9 (H3K9bhb) at the LCN2 promoter, repressing LCN2 transcription; decreased LCN2 in turn weakens NF-κB-RPS3 interaction, reducing NF-κB activity and cardiac injury; LCN2 overexpression reverses BDH1-mediated myocardial protection.","method":"BDH1 KO and AAV-BDH1 overexpression in db/db mice, ChIP (H3K9bhb at LCN2 promoter), H3K9bhb inhibitor (A485), NF-κB/RPS3 co-IP, LCN2 overexpression rescue, transcriptome analysis","journal":"Cardiovascular diabetology","confidence":"High","confidence_rationale":"Tier 1–2 — histone modification ChIP at LCN2 promoter, protein interaction (NF-κB/RPS3), genetic KO/OE with rescue; multiple orthogonal methods","pmids":["40022118"],"is_preprint":false},{"year":2024,"finding":"FBXO2 binds LCN2 via its FBA domain and promotes K27-linked polyubiquitination of LCN2, driving its proteasomal degradation; FBXO2 co-expression reverses LCN2-induced mitochondrial dysfunction and ferroptosis; LCN2 silencing in FBXO2-deficient mice partially restores disc integrity in intervertebral disc degeneration.","method":"Proteomics, co-IP (FBXO2-LCN2 via FBA domain), ubiquitination assay (K27-linked), proteasome inhibitor rescue, LCN2 KD in FBXO2-KO mice, ferroptosis markers","journal":"Advanced science","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical ubiquitination assay with lysine-linkage specificity, co-IP, domain mapping, and genetic validation in vivo","pmids":["40791152"],"is_preprint":false},{"year":2025,"finding":"ROS induces STAT3-mediated MVP transcription; PGAM5 dephosphorylates MVP at S873, enabling MVP to bind LCN2 mRNA and stabilize it, thereby suppressing ferroptosis (reducing lipid peroxidation and intracellular Fe2+) and conferring sorafenib resistance in HCC; disrupting MVP-LCN2 mRNA interaction with tenapanor enhances ferroptosis and sorafenib sensitivity.","method":"RBP screening, MVP-LCN2 mRNA binding assay, PGAM5 dephosphorylation assay (S873 phosphorylation site), LCN2 mRNA stability measurement, ferroptosis assays, tenapanor pharmacological inhibition, HCC cell and in vivo models","journal":"Drug resistance updates","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical dephosphorylation site mapping plus mRNA stabilization mechanism; single study","pmids":["40262414"],"is_preprint":false},{"year":2013,"finding":"Computational modeling (B3LYP DFT calculations + protein-ligand docking) demonstrates that NGAL binds Fe(III)-catecholate complexes (mono-, bis-, tris-catecholate) within its lipocalin binding pocket through a network of hydrogen bonds and electrostatic interactions, providing a structural basis for iron-catecholate binding beyond the known enterobactin interaction.","method":"B3LYP/6-311G(d,p) quantum calculations, protein-ligand flexible docking, Poisson-Boltzmann electrostatic analysis","journal":"Journal of molecular graphics & modelling","confidence":"Low","confidence_rationale":"Tier 4 — computational modeling only, no experimental validation","pmids":["24018130"],"is_preprint":false}],"current_model":"LCN2 (NGAL/24p3) is a secreted lipocalin that functions as an iron-trafficking protein—binding bacterial siderophores to exert bacteriostatic effects and shuttling iron into or out of cells via its receptor (SLC22A17/24p3R) or megalin to modulate apoptosis (iron-loaded form is pro-survival; apo-form depletes iron and activates Bim-dependent apoptosis)—while also forming a stabilizing complex with MMP-9, serving as a direct transcriptional target of NF-κB, C/EBP, Stat5, and Foxo3a (downstream of IL-17, BCR-ABL, PI3K/Akt, and EGFR/HIF-1α signaling), promoting EMT via the ERα/Slug axis, suppressing autophagic flux to enhance ischemia-induced apoptosis, regulating hepatic lipid droplet formation through PLIN5, driving ferroptosis resistance by sequestering iron (regulated epigenetically by H3K9bhb and by FBXO2-mediated K27-ubiquitination for degradation), and modulating neuroinflammation through astrocytic exosome secretion downstream of NOX-NF-κB and NHE1 signaling."},"narrative":{"teleology":[{"year":1993,"claim":"Identification of LCN2 as a lipocalin physically complexed with MMP-9 in neutrophils established the gene product and its first known protein partner, raising the question of what ligand this lipocalin binds and what biological function the NGAL–MMP-9 complex serves.","evidence":"Immunoprecipitation and protein purification from human neutrophils","pmids":["7683678"],"confidence":"High","gaps":["The physiological ligand of the lipocalin pocket was unknown","Whether NGAL modulates MMP-9 enzymatic activity or merely stabilizes it was not resolved","Function beyond neutrophils was unexplored"]},{"year":2001,"claim":"Discovery that secreted 24p3/LCN2 induces apoptosis in hematopoietic cells via an autocrine mechanism linked to a specific cell-surface receptor revealed the protein as a cytokine-like effector of cell death, not merely a structural lipocalin.","evidence":"DNA microarray after IL-3 withdrawal, conditioned medium transfer apoptosis assays in FL5.12 cells","pmids":["11486081"],"confidence":"High","gaps":["The receptor identity was unknown","The role of iron in apoptosis induction was not yet established","Whether LCN2-mediated apoptosis operates in non-hematopoietic cells was unclear"]},{"year":2005,"claim":"Three studies converged to establish LCN2 as a siderophore-dependent iron transporter with two distinct receptors (megalin and 24p3R/SLC22A17) and opposing biological outcomes depending on iron loading: holo-LCN2 delivers iron and promotes survival, while apo-LCN2 depletes intracellular iron and triggers Bim-dependent apoptosis.","evidence":"Surface plasmon resonance for megalin binding; in vivo kidney ischemia-reperfusion rescue with gallium blockade; receptor identification with iron-loaded vs. apo-protein internalization and Bim induction assays","pmids":["15670845","15711640","16377555"],"confidence":"High","gaps":["The identity of endogenous mammalian siderophores remained uncertain","How 24p3R mediates iron efflux mechanistically was unresolved","Whether megalin and 24p3R have tissue-specific or redundant roles was not clarified"]},{"year":2006,"claim":"Mapping of the LCN2 promoter identified NF-κB and C/EBP as essential transcriptional drivers downstream of IL-17/TNFα, and subsequent studies placed Foxo3a (repressed by PI3K/Akt) and Stat5 (activated by BCR-ABL) as additional direct regulators, establishing a rich transcriptional control logic linking LCN2 to inflammatory, survival, and oncogenic signaling.","evidence":"Promoter deletion/reporter assays for NF-κB/C/EBP; ChIP for Foxo3a and Stat5 binding; epistasis with constitutively active Akt and BCR-ABL pathway inhibitors","pmids":["16798734","19056725","19229297"],"confidence":"High","gaps":["Relative contributions of each transcription factor in different tissues were not quantified","Chromatin-level regulation (enhancers, epigenetic marks) was not addressed","Post-transcriptional regulation of LCN2 mRNA was unexplored"]},{"year":2007,"claim":"NGAL-deficient mice demonstrated that siderophore sequestration confers bacteriostatic innate immunity, while LPS/TLR4 signaling was shown to induce LCN2 via NF-κB in macrophages and C/EBP in epithelial cells, linking pathogen sensing to LCN2 expression.","evidence":"NGAL-KO mice with increased bacterial growth; TLR4-mutant (C3H/HeJ) mice with abrogated LCN2 induction; EMSA for NF-κB and C/EBP","pmids":["17229907","17490638"],"confidence":"High","gaps":["Contribution of siderophore-independent mechanisms to host defense was not dissected","Whether LCN2 targets specific bacterial species preferentially was unclear"]},{"year":2009,"claim":"LCN2 was shown to promote epithelial-to-mesenchymal transition in breast cancer by suppressing ERα and inducing Slug, establishing a pro-metastatic role verified by increased invasion and lymph node metastasis in orthotopic models.","evidence":"LCN2 overexpression/silencing with EMT marker analysis, ERα rescue, orthotopic mouse model","pmids":["19237579"],"confidence":"High","gaps":["Whether iron-binding status affects EMT promotion was not tested","Relevance to non-breast cancer EMT was not established","Direct versus indirect mechanism of ERα suppression was unclear"]},{"year":2011,"claim":"24p3-null mice revealed that LCN2-mediated Bim induction is required for normal apoptotic turnover across multiple hematopoietic lineages, confirming in vivo the iron-efflux/Bim axis as a broad physiological cell-death mechanism rather than an in vitro artifact.","evidence":"24p3-KO mice in two backgrounds with apoptosis assays across neutrophils, mast cells, thymocytes, and erythroid cells; competitive repopulation","pmids":["21507940"],"confidence":"High","gaps":["Whether 24p3R is the sole receptor mediating this effect in vivo was not formally tested","Mechanism linking iron depletion to Bim transcription was not defined"]},{"year":2013,"claim":"24p3-deficient neutrophils showed impaired chemotaxis, extravasation, and phagocytosis via cytoskeletal gene suppression and microRNA upregulation, revealing a siderophore-independent function of LCN2 in innate immune cell motility.","evidence":"24p3-KO mice with Listeria/Candida/Staphylococcus infection, neutrophil functional assays, transcriptome and microRNA profiling","pmids":["23543755"],"confidence":"High","gaps":["Which microRNAs are directly regulated by LCN2 was not established","Whether the cytoskeletal effect is iron-dependent was untested"]},{"year":2014,"claim":"LCN2 was shown to regulate hepatic lipid droplet formation through control of PLIN5 expression, extending its metabolic roles beyond iron trafficking.","evidence":"Lcn2-KO mice on MCD/high-fat diets, adenoviral LCN2 reconstitution restoring PLIN5 and lipid droplets","pmids":["25086218"],"confidence":"High","gaps":["Whether LCN2 regulates PLIN5 transcriptionally or post-transcriptionally was not defined","Iron dependence of this lipid-metabolism function was not assessed"]},{"year":2017,"claim":"LCN2 was found to suppress protective autophagy in cardiomyocytes during ischemia by inhibiting AMPK/ULK1 signaling and lysosomal function, thereby exacerbating cytochrome c release and apoptosis—a mechanism distinct from its canonical iron-efflux apoptosis pathway.","evidence":"Lcn2-KO mice with coronary ligation, multiple autophagy readouts (LC3, p62, TEM, tandem LC3 assay), DN-Atg5 epistasis","pmids":["27800610"],"confidence":"High","gaps":["How LCN2 inhibits AMPK mechanistically was not resolved","Whether this autophagy-suppressive function occurs in other tissues was unknown"]},{"year":2021,"claim":"LCN2 was established as a key ferroptosis regulator: NF-κB-driven LCN2 upregulation sequesters iron to confer ferroptosis resistance in hepatocellular carcinoma, while LCN2-neutralizing antibody sensitizes tumors to sorafenib, opening a therapeutic axis.","evidence":"Hepatocyte-specific Lifr-KO mice, NF-κB pathway analysis, ferroptosis assays, LCN2-neutralizing antibody in PDX model","pmids":["34921145"],"confidence":"High","gaps":["Whether LCN2-mediated ferroptosis resistance generalizes beyond HCC was not shown","The siderophore identity mediating iron sequestration in cancer was unresolved"]},{"year":2022,"claim":"Astrocytic LCN2 was identified as a neuroinflammatory mediator: NHE1–NOX–NF-κB signaling drives LCN2 secretion in exosomes from reactive astrocytes, which induce neuronal death after stroke, establishing a paracrine neurotoxic mechanism.","evidence":"Astrocyte-specific Nhe1-KO mice in stroke model, exosome isolation, NOX/NF-κB inhibitors, neuronal viability assays","pmids":["35440572"],"confidence":"High","gaps":["Whether LCN2 is the sole neurotoxic cargo in astrocytic exosomes was not determined","Neuronal receptor mediating exosome-delivered LCN2 toxicity was not identified"]},{"year":2023,"claim":"Multiple 2023 studies expanded the ferroptosis/cancer axis: tissue-infiltrating neutrophils were identified as the primary LCN2 source driving ferroptosis-mediated cachexia, LCN2 was shown to bind SLC3A2 to inhibit GSH/GPX4, and LCN2 was found to bind EGFR and enhance its recycling to activate MEK-ERK signaling in oral cancer, while a MafG/MYH9 complex was identified as a novel transcriptional activator via MARE motifs in the LCN2 promoter conferring hepatic stellate cell ferroptosis resistance.","evidence":"Myeloid-specific Lcn2-KO and neutrophil depletion in cachexia models; co-IP of LCN2–SLC3A2; MS-identified LCN2–EGFR interaction with recycling assays and PDX validation; co-IP of MafG–MYH9 with MARE mutagenesis and LCN2 reconstitution in HSCs","pmids":["36973755","37130481","36899380","38871948"],"confidence":"High","gaps":["Whether LCN2–SLC3A2 interaction is direct or requires iron/siderophore was not established","EGFR recycling mechanism (trafficking machinery) was not defined","MafG/MYH9 role in non-hepatic LCN2 regulation was not tested"]},{"year":2023,"claim":"Proteasome inhibition (stabilizing IκBα to suppress NF-κB) and mTOR inhibition (activating autophagic degradation of LCN2) were identified as two mechanistically distinct strategies to reduce astrocytic LCN2 secretion, with the N-terminal signal peptide required for both secretion and pre-secretory autophagic targeting.","evidence":"LPS-stimulated primary astrocytes with bortezomib and mTOR inhibitor, signal peptide deletion mutants, autophagy flux assays, neuronal viability","pmids":["36781380"],"confidence":"High","gaps":["Whether signal peptide-mediated autophagic targeting is unique to LCN2 or generalizable was unknown","In vivo validation of these suppressive strategies was not provided"]},{"year":2024,"claim":"Two epigenetic/post-translational regulatory layers were defined: H3K9 β-hydroxybutyrylation at the LCN2 promoter activates transcription (repressed by BDH1-mediated ketone rebalancing), and FBXO2 targets LCN2 for K27-linked polyubiquitination and proteasomal degradation, revealing that LCN2 protein levels are tightly controlled by both chromatin and ubiquitin-proteasome pathways.","evidence":"ChIP for H3K9bhb at LCN2 promoter with BDH1-KO/OE and A485 inhibitor; FBXO2–LCN2 co-IP with FBA domain mapping, K27-linkage ubiquitination assay, proteasome inhibitor rescue, FBXO2-KO mice","pmids":["40022118","40791152"],"confidence":"High","gaps":["Which lysine residues on LCN2 are K27-ubiquitinated was not mapped","Whether H3K9bhb regulation of LCN2 occurs in non-cardiac tissues was not tested","Interplay between ubiquitination and autophagic degradation of LCN2 was not examined"]},{"year":2025,"claim":"Post-transcriptional stabilization of LCN2 mRNA by the vault protein MVP (dephosphorylated at S873 by PGAM5) was identified as a mechanism of ferroptosis resistance and sorafenib resistance in HCC, with tenapanor disrupting the MVP–LCN2 mRNA interaction.","evidence":"RBP screening, MVP–LCN2 mRNA binding and stability assays, PGAM5 dephosphorylation at S873, tenapanor treatment in HCC cells and in vivo","pmids":["40262414"],"confidence":"Medium","gaps":["The RNA element in LCN2 mRNA recognized by MVP was not mapped","Independent replication of MVP–LCN2 mRNA axis is needed","Whether this mechanism operates outside HCC was not addressed"]},{"year":null,"claim":"The identity of endogenous mammalian siderophores that bind LCN2 remains poorly characterized, the structural basis of LCN2's siderophore-independent functions (cytoskeletal regulation, autophagy suppression, EGFR recycling) is largely undefined, and the relative contributions of 24p3R versus megalin in different tissues and disease contexts have not been systematically resolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["Endogenous mammalian siderophore identity remains elusive","Structural mechanism for LCN2–EGFR and LCN2–SLC3A2 interactions not resolved at atomic level","Tissue-specific receptor usage (24p3R vs. megalin) not systematically mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,1,5,7,35]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[5,6,7,21]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[7,22,26]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[20,22,28]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,3,5,7,21,23,26]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[23,24]},{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[18]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,7,8,11,16,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,10,13,15,22,28,32]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[3,6,14,20,22,26]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[5,6,18,21]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[10,12,22,26,34]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[20,25]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[30]}],"complexes":["NGAL-MMP9","LCN2-LOXL2-MMP9"],"partners":["MMP9","SLC22A17","LRP2","EGFR","FBXO2","LOXL2","SLC3A2","MVP"],"other_free_text":[]},"mechanistic_narrative":"LCN2 (NGAL/24p3) is a secreted lipocalin that functions as an iron-trafficking protein central to innate immunity, cell survival decisions, and ferroptosis regulation. It captures bacterial siderophores to restrict iron availability during infection and shuttles iron into or out of cells via its receptors SLC22A17 (24p3R) and megalin: iron-loaded LCN2 promotes cell survival, whereas apo-LCN2 induces iron efflux and Bim-dependent apoptosis [PMID:16377555, PMID:15711640, PMID:21507940]. LCN2 is transcriptionally activated by NF-κB, C/EBP, Foxo3a, Stat5, and HIF-1α downstream of diverse signals including IL-17, BCR-ABL, EGFR, and TLR4, and is epigenetically regulated by H3K9 β-hydroxybutyrylation and post-translationally targeted for FBXO2-mediated K27-linked ubiquitination and proteasomal degradation [PMID:16798734, PMID:19056725, PMID:40022118, PMID:40791152]. Beyond iron sequestration, LCN2 stabilizes MMP-9, promotes epithelial-to-mesenchymal transition through ERα/Slug suppression, attenuates protective autophagy in ischemic cardiomyocytes, drives ferroptosis in cachexia-associated tissues, confers ferroptosis resistance in hepatocellular carcinoma and hepatic stellate cells, and mediates neuroinflammatory injury through astrocytic exosome secretion [PMID:7683678, PMID:19237579, PMID:27800610, PMID:36973755, PMID:34921145, PMID:35440572]."},"prefetch_data":{"uniprot":{"accession":"P80188","full_name":"Neutrophil gelatinase-associated lipocalin","aliases":["25 kDa alpha-2-microglobulin-related subunit of MMP-9","Lipocalin-2","Oncogene 24p3","Siderocalin","p25"],"length_aa":198,"mass_kda":22.6,"function":"Iron-trafficking protein involved in multiple processes such as apoptosis, innate immunity and renal development (PubMed:12453413, PubMed:20581821, PubMed:27780864). Binds iron through association with 2,3-dihydroxybenzoic acid (2,3-DHBA), a siderophore that shares structural similarities with bacterial enterobactin, and delivers or removes iron from the cell, depending on the context. Iron-bound form (holo-24p3) is internalized following binding to the SLC22A17 (24p3R) receptor, leading to release of iron and subsequent increase of intracellular iron concentration. In contrast, association of the iron-free form (apo-24p3) with the SLC22A17 (24p3R) receptor is followed by association with an intracellular siderophore, iron chelation and iron transfer to the extracellular medium, thereby reducing intracellular iron concentration. Involved in apoptosis due to interleukin-3 (IL3) deprivation: iron-loaded form increases intracellular iron concentration without promoting apoptosis, while iron-free form decreases intracellular iron levels, inducing expression of the proapoptotic protein BCL2L11/BIM, resulting in apoptosis (By similarity). Involved in innate immunity; limits bacterial proliferation by sequestering iron bound to microbial siderophores, such as enterobactin (PubMed:27780864). Can also bind siderophores from M.tuberculosis (PubMed:15642259, PubMed:21978368)","subcellular_location":"Secreted; Cytoplasmic granule lumen; Cytoplasmic vesicle lumen","url":"https://www.uniprot.org/uniprotkb/P80188/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LCN2","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/LCN2","total_profiled":1310},"omim":[{"mim_id":"620230","title":"FHF COMPLEX SUBUNIT HOOK-INTERACTING PROTEIN 2B; FHIP2B","url":"https://www.omim.org/entry/620230"},{"mim_id":"614995","title":"INTERLEUKIN 17 RECEPTOR E; IL17RE","url":"https://www.omim.org/entry/614995"},{"mim_id":"613609","title":"HOMEOSTATIC IRON REGULATOR; HFE","url":"https://www.omim.org/entry/613609"},{"mim_id":"611461","title":"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 17; SLC22A17","url":"https://www.omim.org/entry/611461"},{"mim_id":"606611","title":"DEFENSIN, BETA, 103A; DEFB103A","url":"https://www.omim.org/entry/606611"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Endoplasmic reticulum","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":2617.2},{"tissue":"gallbladder","ntpm":2090.7},{"tissue":"salivary gland","ntpm":1266.0}],"url":"https://www.proteinatlas.org/search/LCN2"},"hgnc":{"alias_symbol":["NGAL","24p3"],"prev_symbol":[]},"alphafold":{"accession":"P80188","domains":[{"cath_id":"2.40.128.20","chopping":"45-188","consensus_level":"high","plddt":97.2651,"start":45,"end":188}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P80188","model_url":"https://alphafold.ebi.ac.uk/files/AF-P80188-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P80188-F1-predicted_aligned_error_v6.png","plddt_mean":91.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LCN2","jax_strain_url":"https://www.jax.org/strain/search?query=LCN2"},"sequence":{"accession":"P80188","fasta_url":"https://rest.uniprot.org/uniprotkb/P80188.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P80188/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P80188"}},"corpus_meta":[{"pmid":"7683678","id":"PMC_7683678","title":"Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7683678","citation_count":978,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18725016","id":"PMC_18725016","title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.","date":"2008","source":"American journal of kidney diseases : the official journal of the National Kidney Foundation","url":"https://pubmed.ncbi.nlm.nih.gov/18725016","citation_count":456,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22513004","id":"PMC_22513004","title":"The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22513004","citation_count":443,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34921145","id":"PMC_34921145","title":"A targetable LIFR-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34921145","citation_count":261,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19582588","id":"PMC_19582588","title":"NGAL: a biomarker of acute kidney injury and other systemic conditions.","date":"2009","source":"International urology and nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/19582588","citation_count":168,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37445650","id":"PMC_37445650","title":"The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL).","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37445650","citation_count":153,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2542864","id":"PMC_2542864","title":"SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism.","date":"1989","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2542864","citation_count":143,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9842963","id":"PMC_9842963","title":"Heterogeneous expression of the lipocalin NGAL in primary breast cancers.","date":"1998","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9842963","citation_count":135,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29739822","id":"PMC_29739822","title":"More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases.","date":"2018","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/29739822","citation_count":107,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1834059","id":"PMC_1834059","title":"Mouse oncogene protein 24p3 is a member of the lipocalin protein family.","date":"1991","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/1834059","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27729871","id":"PMC_27729871","title":"Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy.","date":"2016","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27729871","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36150522","id":"PMC_36150522","title":"Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury - A systematic review.","date":"2022","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36150522","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24742531","id":"PMC_24742531","title":"Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24742531","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27634444","id":"PMC_27634444","title":"The Update of NGAL in Acute Kidney Injury.","date":"2017","source":"Current protein & peptide science","url":"https://pubmed.ncbi.nlm.nih.gov/27634444","citation_count":92,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20415702","id":"PMC_20415702","title":"From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology.","date":"2010","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/20415702","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17490638","id":"PMC_17490638","title":"Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver.","date":"2007","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17490638","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26278055","id":"PMC_26278055","title":"Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26278055","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36781380","id":"PMC_36781380","title":"Reduced secretion of LCN2 (lipocalin 2) from reactive astrocytes through autophagic and proteasomal regulation alleviates inflammatory stress and neuronal damage.","date":"2023","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/36781380","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36973755","id":"PMC_36973755","title":"LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia.","date":"2023","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36973755","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35440572","id":"PMC_35440572","title":"NOX activation in reactive astrocytes regulates astrocytic LCN2 expression and neurodegeneration.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35440572","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20960272","id":"PMC_20960272","title":"Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus.","date":"2010","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/20960272","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23543755","id":"PMC_23543755","title":"Impaired neutrophil function in 24p3 null mice contributes to enhanced susceptibility to bacterial infections.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23543755","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23884139","id":"PMC_23884139","title":"Albuminuria induces a proinflammatory and profibrotic response in cortical collecting ducts via the 24p3 receptor.","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23884139","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16377555","id":"PMC_16377555","title":"24p3 and its receptor: dawn of a new iron age?","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16377555","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28424824","id":"PMC_28424824","title":"Resistin and NGAL are associated with inflammatory response, endothelial activation and clinical outcomes in sepsis.","date":"2017","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/28424824","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27800610","id":"PMC_27800610","title":"Lipocalin-2 (NGAL) Attenuates Autophagy to Exacerbate Cardiac Apoptosis Induced by Myocardial Ischemia.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27800610","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19732769","id":"PMC_19732769","title":"Lipocalin 2 regulation by thermal stresses: protective role of Lcn2/NGAL against cold and heat stresses.","date":"2009","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19732769","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25086218","id":"PMC_25086218","title":"Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25086218","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10396016","id":"PMC_10396016","title":"Ovarian steroids regulate 24p3 expression in mouse uterus during the natural estrous cycle and the preimplantation period.","date":"1999","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10396016","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25591790","id":"PMC_25591790","title":"Urinary ADAM12 and MMP-9/NGAL complex detect the presence of gastric cancer.","date":"2015","source":"Cancer prevention research (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/25591790","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25087119","id":"PMC_25087119","title":"KIM-1 and NGAL as biomarkers of nephrotoxicity induced by gentamicin in rats.","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25087119","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29755643","id":"PMC_29755643","title":"Tumor associated macrophages deliver iron to tumor cells via Lcn2.","date":"2018","source":"International journal of physiology, pathophysiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29755643","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35341902","id":"PMC_35341902","title":"Glioma-derived exosomes hijack the blood-brain barrier to facilitate nanocapsule delivery via LCN2.","date":"2022","source":"Journal of controlled release : official journal of the Controlled Release Society","url":"https://pubmed.ncbi.nlm.nih.gov/35341902","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24713998","id":"PMC_24713998","title":"Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias.","date":"2014","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/24713998","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30231474","id":"PMC_30231474","title":"Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner?","date":"2018","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/30231474","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12614196","id":"PMC_12614196","title":"Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12614196","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27782193","id":"PMC_27782193","title":"Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27782193","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19727808","id":"PMC_19727808","title":"Neutrophil gelatinase-associated lipocalin (NGAL/Lcn2) is upregulated in gastric mucosa infected with Helicobacter pylori.","date":"2009","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19727808","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19229297","id":"PMC_19229297","title":"Transcription and signalling pathways involved in BCR-ABL-mediated misregulation of 24p3 and 24p3R.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19229297","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31889023","id":"PMC_31889023","title":"CD4+ T Cell-Derived NGAL Modifies the Outcome of Ischemic Acute Kidney Injury.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31889023","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35995279","id":"PMC_35995279","title":"Kdm6a deficiency in microglia/macrophages epigenetically silences Lcn2 expression and reduces photoreceptor dysfunction in diabetic retinopathy.","date":"2022","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/35995279","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36243318","id":"PMC_36243318","title":"Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia.","date":"2022","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/36243318","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36899380","id":"PMC_36899380","title":"Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling.","date":"2023","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/36899380","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29869714","id":"PMC_29869714","title":"Expression of neutrophil gelatinase-associated lipocalin (NGAL) in the gut in Crohn's disease.","date":"2018","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/29869714","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20512104","id":"PMC_20512104","title":"Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle?","date":"2010","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/20512104","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22418433","id":"PMC_22418433","title":"Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22418433","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37130481","id":"PMC_37130481","title":"Dihydromyricetin attenuates intracerebral hemorrhage by reversing the effect of LCN2 via the system Xc- pathway.","date":"2023","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37130481","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38871948","id":"PMC_38871948","title":"MafG/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/38871948","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29321030","id":"PMC_29321030","title":"CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension.","date":"2018","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29321030","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17420078","id":"PMC_17420078","title":"Apoptosis induced by uterine 24p3 protein in endometrial carcinoma cell line.","date":"2007","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/17420078","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24837251","id":"PMC_24837251","title":"Serum and urinary NGAL but not KIM-1 raises in human postrenal AKI.","date":"2014","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24837251","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29980183","id":"PMC_29980183","title":"NGAL protects against endotoxin-induced renal tubular cell damage by suppressing apoptosis.","date":"2018","source":"BMC nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/29980183","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34601488","id":"PMC_34601488","title":"TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34601488","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39836995","id":"PMC_39836995","title":"Regulating astrocyte phenotype by Lcn2 inhibition toward ischemic stroke therapy.","date":"2025","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/39836995","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32692467","id":"PMC_32692467","title":"LncRNA TMPO-AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32692467","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34255268","id":"PMC_34255268","title":"Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis.","date":"2021","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/34255268","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38640713","id":"PMC_38640713","title":"Berberine alleviates neuroinflammation by downregulating NFκB/LCN2 pathway in sepsis-associated encephalopathy: network pharmacology, bioinformatics, and experimental validation.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38640713","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37753805","id":"PMC_37753805","title":"A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer.","date":"2023","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37753805","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17350462","id":"PMC_17350462","title":"Lipocalin 24p3 is regulated by the Wnt pathway independent of regulation by iron.","date":"2007","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/17350462","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38171248","id":"PMC_38171248","title":"LCN2: Versatile players in breast cancer.","date":"2024","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/38171248","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28596835","id":"PMC_28596835","title":"Chronic diazepam administration increases the expression of Lcn2 in the CNS.","date":"2017","source":"Pharmacology research & perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/28596835","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39424639","id":"PMC_39424639","title":"Tumor-secreted LCN2 impairs gastric cancer progression via autocrine inhibition of the 24p3R/JNK/c-Jun/SPARC axis.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39424639","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26503619","id":"PMC_26503619","title":"Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) and proteinuria predict severity of acute kidney injury in Puumala virus infection.","date":"2015","source":"BMC infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/26503619","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29089666","id":"PMC_29089666","title":"Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer.","date":"2017","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/29089666","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27477830","id":"PMC_27477830","title":"Upregulation of lipocalin-2 (LCN2) in osteoarthritic cartilage is not necessary for cartilage destruction in mice.","date":"2016","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/27477830","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30403420","id":"PMC_30403420","title":"Validation of an ELISA for detection of neutrophil gelatinase-associated lipocalin (NGAL) in equine serum.","date":"2018","source":"Veterinary clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30403420","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37429840","id":"PMC_37429840","title":"Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer's disease.","date":"2023","source":"NPJ Regenerative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37429840","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31994917","id":"PMC_31994917","title":"Association between neutrophil gelatinase-associated lipocalin (NGAL) and iron profile in chronic renal disease.","date":"2020","source":"Archives of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31994917","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21507940","id":"PMC_21507940","title":"Multiple apoptotic defects in hematopoietic cells from mice lacking lipocalin 24p3.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21507940","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31129920","id":"PMC_31129920","title":"CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31129920","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28185846","id":"PMC_28185846","title":"Corticoids synergize with IL-1 in the induction of LCN2.","date":"2017","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/28185846","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24018130","id":"PMC_24018130","title":"Modeling iron-catecholates binding to NGAL protein.","date":"2013","source":"Journal of molecular graphics & modelling","url":"https://pubmed.ncbi.nlm.nih.gov/24018130","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34298880","id":"PMC_34298880","title":"Increased Endocytosis of Cadmium-Metallothionein through the 24p3 Receptor in an In Vivo Model with Reduced Proximal Tubular Activity.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34298880","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27590891","id":"PMC_27590891","title":"Serum NGAL and copeptin levels as predictors of acute kidney injury in asphyxiated neonates.","date":"2016","source":"Clinical and experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/27590891","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31967970","id":"PMC_31967970","title":"ERα-dependent stimulation of LCN2 in uterine epithelium during mouse early pregnancy.","date":"2020","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31967970","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40025014","id":"PMC_40025014","title":"LCN2 induces neuronal loss and facilitates sepsis-associated cognitive impairments.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/40025014","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38295916","id":"PMC_38295916","title":"Lipocalin 2 (LCN2) confers acquired resistance to almonertinib in NSCLC through LCN2-MMP-9 signaling pathway.","date":"2024","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/38295916","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33604288","id":"PMC_33604288","title":"LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33604288","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32758668","id":"PMC_32758668","title":"Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cells.","date":"2020","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/32758668","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20860895","id":"PMC_20860895","title":"NGAL immunohistochemical expression in brain primary and metastatic tumors.","date":"2010","source":"Clinical neuropathology","url":"https://pubmed.ncbi.nlm.nih.gov/20860895","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35053376","id":"PMC_35053376","title":"Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35053376","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27997859","id":"PMC_27997859","title":"Interleukin-1β as a driver of renal NGAL production.","date":"2016","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/27997859","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17304338","id":"PMC_17304338","title":"Mouse 24p3 protein has an effect on L929 cell viability.","date":"2007","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17304338","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31233712","id":"PMC_31233712","title":"LCN2-interacting proteins and their expression patterns in brain tumors.","date":"2019","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/31233712","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40022118","id":"PMC_40022118","title":"BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2.","date":"2025","source":"Cardiovascular diabetology","url":"https://pubmed.ncbi.nlm.nih.gov/40022118","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40225581","id":"PMC_40225581","title":"Microglial Lcn2 knockout enhances chronic intracerebral hemorrhage recovery by restoring myelin and reducing inflammation.","date":"2025","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/40225581","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39032282","id":"PMC_39032282","title":"Withaferin A protects against epilepsy by promoting LCN2-mediated astrocyte polarization to stopping neuronal ferroptosis.","date":"2024","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39032282","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21403867","id":"PMC_21403867","title":"Both IL-1β and TNF-α regulate NGAL expression in polymorphonuclear granulocytes of chronic hemodialysis patients.","date":"2011","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/21403867","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40364435","id":"PMC_40364435","title":"Faecalibacterium prausnitzii prevents age-related heart failure by suppressing ferroptosis in cardiomyocytes through butyrate-mediated LCN2 regulation.","date":"2025","source":"Gut microbes","url":"https://pubmed.ncbi.nlm.nih.gov/40364435","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24423438","id":"PMC_24423438","title":"NGAL can alternately mediate sunitinib resistance in renal cell carcinoma.","date":"2014","source":"The Journal of urology","url":"https://pubmed.ncbi.nlm.nih.gov/24423438","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26539647","id":"PMC_26539647","title":"C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.","date":"2015","source":"Renal failure","url":"https://pubmed.ncbi.nlm.nih.gov/26539647","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38761990","id":"PMC_38761990","title":"Knockdown of LncRNA Lcn2-204 alleviates sepsis-induced myocardial injury by regulation of iron overload and ferroptosis.","date":"2024","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/38761990","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40083945","id":"PMC_40083945","title":"LCN2 deficiency mitigates the neuroinflammatory damage following acute glaucoma.","date":"2025","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/40083945","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19056725","id":"PMC_19056725","title":"Identification of 24p3 as a direct target of Foxo3a regulated by interleukin-3 through the phosphoinositide 3-kinase/Akt pathway.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19056725","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15055523","id":"PMC_15055523","title":"The 24p3 gene is induced during involution of the mammary gland and induces apoptosis of mammary epithelial cells.","date":"2004","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/15055523","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40262414","id":"PMC_40262414","title":"MVP-LCN2 axis triggers evasion of ferroptosis to drive hepatocarcinogenesis and sorafenib resistance.","date":"2025","source":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/40262414","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37298232","id":"PMC_37298232","title":"Expression Analysis of Lipocalin 2 (LCN2) in Reproductive and Non-Reproductive Tissues of Esr1-Deficient Mice.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37298232","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14703690","id":"PMC_14703690","title":"The lipocalin 24p3, which is an essential molecule in IL-3 withdrawal-induced apoptosis, is not involved in the G-CSF withdrawal-induced apoptosis.","date":"2003","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/14703690","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38395264","id":"PMC_38395264","title":"G-4 inhibits triple negative breast cancer by inducing cell apoptosis and promoting LCN2-dependent ferroptosis.","date":"2024","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38395264","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40791152","id":"PMC_40791152","title":"FBXO2 Alleviates Intervertebral Disc Degeneration via Dual Mechanisms: Activating PINK1-Parkin Mitophagy and Ubiquitinating LCN2 to Suppress Ferroptosis.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40791152","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19850388","id":"PMC_19850388","title":"Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis.","date":"2009","source":"American journal of kidney diseases : the official journal of the National Kidney Foundation","url":"https://pubmed.ncbi.nlm.nih.gov/19850388","citation_count":982,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15711640","id":"PMC_15711640","title":"Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15711640","citation_count":756,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17229907","id":"PMC_17229907","title":"Dual action of neutrophil gelatinase-associated lipocalin.","date":"2007","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/17229907","citation_count":596,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18337554","id":"PMC_18337554","title":"Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study.","date":"2008","source":"Clinical journal of the American Society of Nephrology : CJASN","url":"https://pubmed.ncbi.nlm.nih.gov/18337554","citation_count":579,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21511111","id":"PMC_21511111","title":"The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.","date":"2011","source":"Journal of the American College of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/21511111","citation_count":536,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9339356","id":"PMC_9339356","title":"Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9339356","citation_count":485,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21836143","id":"PMC_21836143","title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery.","date":"2011","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/21836143","citation_count":449,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19176795","id":"PMC_19176795","title":"Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.","date":"2009","source":"Clinical journal of the American Society of Nephrology : CJASN","url":"https://pubmed.ncbi.nlm.nih.gov/19176795","citation_count":428,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16827865","id":"PMC_16827865","title":"Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation.","date":"2006","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/16827865","citation_count":365,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16335952","id":"PMC_16335952","title":"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.","date":"2005","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/16335952","citation_count":350,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18070344","id":"PMC_18070344","title":"Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study.","date":"2007","source":"Critical care (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18070344","citation_count":347,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28628361","id":"PMC_28628361","title":"Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation.","date":"2017","source":"Annual review of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/28628361","citation_count":336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20921623","id":"PMC_20921623","title":"Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.","date":"2010","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/20921623","citation_count":320,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17874137","id":"PMC_17874137","title":"NGAL is an early predictive biomarker of contrast-induced nephropathy in children.","date":"2007","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/17874137","citation_count":319,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11486081","id":"PMC_11486081","title":"Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11486081","citation_count":311,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19237579","id":"PMC_19237579","title":"Lipocalin 2 promotes breast cancer progression.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19237579","citation_count":309,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16254208","id":"PMC_16254208","title":"Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction.","date":"2005","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16254208","citation_count":297,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15670845","id":"PMC_15670845","title":"The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake.","date":"2005","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15670845","citation_count":283,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21836147","id":"PMC_21836147","title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery.","date":"2011","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/21836147","citation_count":281,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24375576","id":"PMC_24375576","title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.","date":"2014","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/24375576","citation_count":251,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16798734","id":"PMC_16798734","title":"Identification of common transcriptional regulatory elements in interleukin-17 target genes.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16798734","citation_count":250,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51868,"output_tokens":9638,"usd":0.150087},"stage2":{"model":"claude-opus-4-6","input_tokens":13630,"output_tokens":4502,"usd":0.27105},"total_usd":0.893019,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":67513,"output_tokens":10005,"usd":0.176307},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":14240,"output_tokens":5034,"usd":0.295575}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"LCN2/NGAL was isolated as a 25-kDa protein physically associated with human neutrophil gelatinase (MMP-9); the 135-kDa form of gelatinase is a heterodimer of 92-kDa MMP-9 and LCN2, demonstrated by immunoblotting and immunoprecipitation. LCN2 is N-glycosylated and belongs to the lipocalin family.\",\n      \"method\": \"Immunoprecipitation, immunoblotting, protein purification, N-terminal sequencing, N-glycanase treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original biochemical isolation with multiple orthogonal methods; foundational paper with >900 citations\",\n      \"pmids\": [\"7683678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Mouse 24p3 (LCN2) was identified as a member of the lipocalin protein family based on conserved sequence motifs, suggesting a function in ligand binding.\",\n      \"method\": \"Computational sequence analysis with conserved lipocalin motifs\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational/sequence analysis only\",\n      \"pmids\": [\"1834059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LCN2/24p3 induces apoptosis through a receptor (24p3R): iron-loaded LCN2 internalized via 24p3R prevents apoptosis, whereas apo-LCN2 (iron-free) internalized via 24p3R causes cellular iron efflux and apoptosis through the pro-apoptotic protein Bim.\",\n      \"method\": \"Receptor identification and internalization studies, apoptosis assays, iron trafficking experiments\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — receptor-ligand internalization with functional apoptosis readout; published in Cell with mechanistic dissection of iron-loaded vs apo forms\",\n      \"pmids\": [\"16377555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"LCN2/24p3 is induced by IL-3 withdrawal in hematopoietic cells and is essential for IL-3 withdrawal-induced apoptosis; antisense-mediated suppression of 24p3 reduced apoptosis, and 24p3 overexpression increased apoptosis.\",\n      \"method\": \"Antisense cDNA stable transfection, apoptosis assays, caspase-3 cleavage, Bcl-2/Bcl-xL overexpression rescue\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function and overexpression with specific apoptotic phenotype and caspase activation, single lab\",\n      \"pmids\": [\"12614196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"LCN2/24p3 is induced by IL-3 deprivation but not G-CSF deprivation, demonstrating cytokine-specific regulation of LCN2-dependent apoptosis in hematopoietic cells.\",\n      \"method\": \"Cytokine withdrawal, Northern blot, cell growth and apoptosis assays\",\n      \"journal\": \"European journal of haematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function/functional assays showing pathway specificity\",\n      \"pmids\": [\"14703690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"LCN2 stabilizes MMP-9 by forming a complex with it, protecting MMP-9 from autodegradation and thereby sustaining its proteolytic activity.\",\n      \"method\": \"Complex characterization, MMP-9 activity assays (referenced in review context)\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — mechanistic description supported across multiple reviews citing original biochemical work on the NGAL/MMP-9 complex\",\n      \"pmids\": [\"22513004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"LCN2/24p3 induces apoptosis in endometrial carcinoma RL95-2 cells via increased intracellular ROS, mitochondrial membrane potential change, cytochrome c release, and activation of caspases -8, -9, and -3, with DNA condensation.\",\n      \"method\": \"ROS assay, mitochondrial membrane potential assay, caspase activity assays, PI/AnnexinV staining, Western blot\",\n      \"journal\": \"Toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods defining apoptotic mechanism, single lab\",\n      \"pmids\": [\"17420078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"LCN2/24p3 expression is regulated by the Wnt pathway independently of iron levels; Wnt pathway activation decreases 24p3 expression without altering intracellular iron, while iron addition induces 24p3 expression in an independent manner.\",\n      \"method\": \"RT-PCR, Western blot, Wnt pathway activation, iron manipulation\",\n      \"journal\": \"Cancer genetics and cytogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two independent regulatory axes dissected with functional readouts\",\n      \"pmids\": [\"17350462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"LCN2/24p3 upregulation in lung and liver during acute endotoxemia is mediated via TLR4, with downstream activation of NF-κB in macrophages and both NF-κB and C/EBP in alveolar epithelial cells.\",\n      \"method\": \"LPS administration in vivo, TLR4 mutant mice (C3H/HeJ), NF-κB nuclear binding assays, RT-PCR, Western blot, immunohistochemistry\",\n      \"journal\": \"Experimental and molecular pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic (TLR4 mutant) and biochemical (NF-κB) evidence, multiple cell types, in vivo and in vitro\",\n      \"pmids\": [\"17490638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"LCN2/24p3 transcription is directly regulated by Foxo3a binding to the 24p3 promoter; the PI3K/Akt pathway (activated by IL-3) represses 24p3 by phosphorylating and inactivating Foxo3a, whereas PI3K/Akt inhibition induces 24p3 expression and apoptosis.\",\n      \"method\": \"Promoter reporter assay, constitutively active Akt overexpression, Foxo3a chromatin binding, PI3K/Akt and MAPK inhibitors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct promoter binding + gain/loss of function + pathway pharmacology, multiple orthogonal methods\",\n      \"pmids\": [\"19056725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BCR-ABL upregulates LCN2/24p3 expression through the JAK/STAT pathway (specifically STAT5 binding to the 24p3 promoter), and represses the LCN2 receptor 24p3R through a Ras signaling pathway that switches binding from Runx3 (activator) to Runx1 (repressor) at the 24p3R promoter; repression of 24p3R is required for imatinib-induced killing of BCR-ABL+ cells.\",\n      \"method\": \"ChIP showing STAT5 binding to 24p3 promoter and Runx1/Runx3 switching at 24p3R promoter, signaling pathway inhibitors, imatinib functional assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP + pharmacological dissection + functional epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"19229297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Overexpression of LCN2 protects cells against cold-stress-induced apoptosis (decreasing pro-apoptotic proteins and apoptotic cell number), while exogenous recombinant LCN2 exacerbates heat-stress toxicity, revealing context-dependent dual roles. LCN2 also increases HO-1 expression.\",\n      \"method\": \"Overexpression, siRNA knockdown, cell proliferation and apoptosis assays, Western blot, in vivo mouse thermal stress models\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — overexpression and knockdown with specific phenotypic readouts in multiple cell lines\",\n      \"pmids\": [\"19732769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"LCN2/24p3-deficient mice develop progressive accumulation of hematopoietic cells due to apoptotic defects in neutrophils, mast cells, thymocytes, and erythroid cells; resistance to apoptosis in 24p3-/- cells is associated with attenuated Bim responses.\",\n      \"method\": \"24p3 knockout mice, competitive repopulation, apoptosis assays, Bim Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo knockout with multiple hematopoietic lineages examined and Bim mechanistic link\",\n      \"pmids\": [\"21507940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LCN2/NGAL expression is regulated by S2R(Pgrmc1) through EGFR-mediated activation of NF-κB (specifically p65/RelA acetylation and phosphorylation); S2R(Pgrmc1) knockdown decreases LCN2 expression and MMP-9 activity, and LCN2 is required for MMP-9 activity and tumor formation.\",\n      \"method\": \"siRNA knockdown, antibody arrays, qRT-PCR, Western blot, EGFR inhibitors (erlotinib, AG1478), Akt/ERK inhibitors, HDAC inhibitors, NF-κB subunit analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological inhibitors + loss-of-function + NF-κB mechanistic dissection, multiple orthogonal methods\",\n      \"pmids\": [\"22418433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"LCN2-deficient (24p3-/-) mice show impaired neutrophil extravasation, defective chemotaxis, and failure to phagocytose bacteria, leading to enhanced susceptibility to infection; transcriptome analysis revealed selective suppression of cytoskeletal reorganization genes and increased microRNAs targeting upstream regulators of cytoskeletal proteins.\",\n      \"method\": \"24p3-/- knockout mice, infection models, chemotaxis assays, phagocytosis assays, transcriptome analysis, microRNA analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo knockout with multiple orthogonal functional assays and transcriptomic mechanistic data\",\n      \"pmids\": [\"23543755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In cortical collecting duct cells, LCN2/NGAL receptor (24p3R) mediates albumin endocytosis and activates NF-κB and TGF-β1 signaling pathways, leading to a proinflammatory and profibrotic response.\",\n      \"method\": \"Luciferase NF-κB reporter, nuclear translocation of NF-κB p65, FITC-albumin uptake, siRNA knockdown of 24p3R, in vivo nephrotic rat model\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — receptor knockdown + multiple signaling readouts + in vivo validation\",\n      \"pmids\": [\"23884139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LCN2 regulates hepatic lipid homeostasis by controlling intracellular lipid droplet formation through upregulation of PLIN5 (Perilipin 5); LCN2-deficient mice accumulate more hepatic lipids and have reduced PLIN5, and restoration of LCN2 in Lcn2-/- hepatocytes induces PLIN5 and restores lipid droplet formation.\",\n      \"method\": \"Lcn2-knockout mice, MCD diet, adenoviral LCN2 rescue, Western blot, immunohistochemistry, in vitro hepatocyte experiments\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout + rescue with adenoviral vector + in vitro validation, multiple orthogonal methods\",\n      \"pmids\": [\"25086218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LCN2 suppresses autophagic flux in cardiomyocytes, impairing the protective autophagy response to ischemia and thereby exacerbating ischemia-induced apoptosis; LCN2 knockout mice have greater ischemia-induced autophagy and are protected against cardiac dysfunction.\",\n      \"method\": \"Coronary artery ligation in Lcn2 KO mice, echocardiography, LC3/p62 Western blot, TEM, LC3 immunohistochemistry, RFP/GFP-LC3 tandem assay, MagicRed lysosomal assay, AMPK/ULK1 phosphorylation, dominant-negative Atg5 model\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO + multiple in vitro orthogonal autophagy assays + mechanistic signaling\",\n      \"pmids\": [\"27800610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Tumor-associated macrophages (TAMs) secrete LCN2 which acts as an iron transporter to deliver iron to tumor cells, increasing intracellular iron concentration; LCN2-neutralizing antibody blocks this iron delivery.\",\n      \"method\": \"LCN2 measurement in TAM conditioned medium, intracellular iron quantification, LCN2 antibody neutralization\",\n      \"journal\": \"International journal of physiology, pathophysiology and pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — antibody neutralization with functional iron transport readout, single lab\",\n      \"pmids\": [\"29755643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CD4+ T cells produce LCN2 during ischemic AKI; adoptive transfer of NGAL-deficient CD4+ T cells worsened renal outcomes compared to WT CD4+ T cells, and NGAL-deficient CD4+ T cells expressed higher IFN-γ; Th1, Th2, and Th17 differentiation significantly increases Lcn2 expression.\",\n      \"method\": \"RNA-seq, qRT-PCR, ELISA, NGAL KO mice, CD4 KO mice, adoptive T cell transfer, in vitro ischemia/reperfusion simulation, T cell differentiation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO + adoptive transfer + in vitro mechanistic studies, multiple orthogonal methods\",\n      \"pmids\": [\"31889023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LncRNA TMPO-AS1 promotes LCN2 transcriptional activity by binding and sequestering the transcriptional repressor E2F6, which normally binds the LCN2 promoter to repress its expression; E2F6 silencing or LCN2 overexpression rescues tumor cell aggressiveness upon TMPO-AS1 knockdown.\",\n      \"method\": \"siRNA silencing, RNA-IP, chromatin immunoprecipitation, luciferase promoter assay, rescue overexpression\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + RNA-IP + rescue experiments, single lab\",\n      \"pmids\": [\"32692467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss of LIFR activates NF-κB signaling through SHP1, leading to upregulation of LCN2, which depletes iron and confers resistance to ferroptosis inducers; LCN2-neutralizing antibody restores sorafenib sensitivity in HCC.\",\n      \"method\": \"Hepatocyte-specific and inducible Lifr-knockout mice, NF-κB signaling assays, LCN2 measurement, LCN2 neutralizing antibody, PDX tumor models, ferroptosis assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo conditional KO + patient-derived xenograft + neutralizing antibody + mechanistic pathway dissection\",\n      \"pmids\": [\"34921145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NGF binding to TrkA phosphorylates TrkA, activating the MAPK/Erk signaling pathway which increases LCN2/NGAL expression, thereby enhancing MMP-2 and MMP-9 activity to promote colorectal cancer metastasis.\",\n      \"method\": \"Western blot, RT-PCR, ELISA, wound healing, Transwell migration/invasion assay, immunohistochemistry\",\n      \"journal\": \"Clinical & translational oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — signaling pathway dissection with functional metastasis readouts, single lab\",\n      \"pmids\": [\"34255268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Astrocytic NOX (NADPH oxidase)-NF-κB signaling drives LCN2 expression and secretion; LCN2 is secreted from reactive astrocytes into exosomes and causes neuronal apoptosis and neurite degeneration; inhibition of astrocytic NHE1 attenuates NOX signaling and LCN2-mediated neurotoxicity.\",\n      \"method\": \"Astrocyte-specific Nhe1 knockout mice, stroke model, LCN2 exosome quantification, NeuN+ neuron counting, in vitro ischemia, HOE642 NHE1 inhibition, NOX/NF-κB pathway analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO + pharmacological inhibition + exosome mechanistic link + neuronal death readout\",\n      \"pmids\": [\"35440572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Kdm6a (a histone H3K27 demethylase) in microglia/macrophages activates Lcn2 expression in a demethylase activity-dependent manner, and Lcn2 inhibits glycolysis in photoreceptor cells; conditional Kdm6a knockout reduces Lcn2 and ameliorates diabetic retinopathy.\",\n      \"method\": \"Conditional Kdm6a knockout mice, RNA-seq, mass spectrometry, immunohistochemistry, enzyme activity assays\",\n      \"journal\": \"Metabolism: clinical and experimental\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional knockout + demethylase activity dependence + downstream glycolysis measurement\",\n      \"pmids\": [\"35995279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"LCN2 mediates adipocyte-muscle-tumor crosstalk in pancreatic cancer cachexia; adipocyte-secreted LCN2 (induced by PDAC-conditioned medium) suppresses thermogenesis (inhibiting Ucp1 and β3-AR in BAT) and promotes muscle atrophy (increasing MuRF-1 and Fbx32); Lcn2 knockout or anti-Lcn2 antibody prevents fat and muscle wasting and hypothermia.\",\n      \"method\": \"Lcn2-knockout mice, anti-Lcn2 antibody neutralization, conditioned medium experiments, adipocyte/muscle cell co-culture, in vivo PDAC model\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO + antibody neutralization + mechanistic thermogenesis/atrophy readouts\",\n      \"pmids\": [\"36243318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LCN2 binds to EGFR and enhances EGFR recycling back to the plasma membrane, thereby activating the EGFR-MEK-ERK cascade and promoting OSCC proliferation and metastasis; LCN2 inhibition reduces EGFR phosphorylation and downstream signaling.\",\n      \"method\": \"Mass spectrometry, co-immunoprecipitation, immunofluorescence, EGFR phosphorylation assays, in vitro and in vivo siRNA nanoparticle delivery\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP showing direct LCN2-EGFR interaction + receptor recycling assay + downstream signaling + in vivo validation\",\n      \"pmids\": [\"36899380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Proteasome inhibition suppresses NF-κB activation through NFKBIA/IκBα stabilization in astrocytes, reducing LCN2 expression; autophagic flux activation (via mTOR inhibition) reduces LCN2 through pre-secretory lysosomal degradation dependent on LCN2's N-terminal signal peptide; both pathways reduce secreted LCN2 and increase neuronal viability.\",\n      \"method\": \"Primary astrocyte cultures, proteasome inhibitor (bortezomib), mTOR inhibitor, LPS treatment, siRNA knockdown, LCN2 signal peptide deletion constructs, ELISA, Western blot, neuronal viability assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent regulatory mechanisms with orthogonal pharmacology + mechanistic domain (signal peptide) requirement\",\n      \"pmids\": [\"36781380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Tissue-infiltrating neutrophils (TI-Neu) secrete LCN2 which induces ferroptosis in adipose and muscle tissue, causing cancer cachexia wasting; antibody depletion of TI-Neu and myeloid-specific Lcn2 knockout prevent ferroptosis and tissue wasting.\",\n      \"method\": \"Myeloid-specific Lcn2 knockout mice, antibody depletion of TI-Neu, chemical ferroptosis inhibition, in vivo mouse lung cancer cachexia model, human patient samples\",\n      \"journal\": \"Journal of hematology & oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO + antibody depletion + pharmacological ferroptosis inhibition, multiple mechanistic approaches\",\n      \"pmids\": [\"36973755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LCN2 binds to SLC3A2 (system Xc- component) and inhibits downstream glutathione (GSH) synthesis and GPX4 expression, promoting ferroptosis; this was demonstrated by molecular docking and co-immunoprecipitation.\",\n      \"method\": \"Co-immunoprecipitation, molecular docking, Western blot for GPX4 and GSH, LCN2 overexpression rescue, proteomics\",\n      \"journal\": \"Phytomedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP + molecular docking + functional ferroptosis readouts, single lab\",\n      \"pmids\": [\"37130481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Ngfr/NGFR suppresses reactive astrocyte LCN2 expression; elevated LCN2 reduces neurogenesis in astroglia through Slc22a17 (the 24p3 receptor), and blockage of Slc22a17 recapitulates the pro-neurogenic effect of Ngfr.\",\n      \"method\": \"APP/PS1dE9 mouse model, AAV-mediated Ngfr expression, single-cell transcriptomics, spatial proteomics, Lcn2/Slc22a17 knockdown, histological proliferation/neurogenesis analysis, 3D human astroglial cultures\",\n      \"journal\": \"NPJ Regenerative medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo AAV + knockdown + single-cell transcriptomics + functional neurogenesis readouts + human validation\",\n      \"pmids\": [\"37429840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MafG physically interacts with MYH9 to form a complex that transcriptionally activates LCN2 expression by binding to the MARE motif in the LCN2 promoter; LCN2 in turn suppresses ferroptosis in hepatic stellate cells to promote liver fibrosis; site-directed mutation of the MARE motif blocks MafG binding to LCN2 promoter.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, site-directed mutagenesis, LCN2 re-expression rescue, AAV6-mediated HSC-specific MafG knockdown, BDL liver fibrosis mouse model, ferroptosis assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP + mutagenesis + co-IP + in vivo AAV KD + rescue experiments, multiple orthogonal methods\",\n      \"pmids\": [\"38871948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LCN2 binds to its receptor 24p3R via autocrine signaling and directly inhibits JNK phosphorylation, suppressing the JNK/c-Jun/SPARC axis to impair gastric cancer progression; c-Jun acts as a transcription factor inducing SPARC expression downstream.\",\n      \"method\": \"Transcriptome sequencing, Western blot, co-immunoprecipitation (LCN2-24p3R), JNK phosphorylation assays, in vitro/in vivo overexpression and knockdown, clinical correlation\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP demonstrating LCN2-24p3R interaction + kinase signaling pathway + functional phenotype, single lab\",\n      \"pmids\": [\"39424639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BDH1 overexpression reprograms ketone metabolism to decrease β-hydroxybutyrylation of histone H3K9 at the LCN2 promoter, thereby epigenetically repressing LCN2 transcription; LCN2 normally promotes NF-κB activity by strengthening interaction between NF-κB and RPS3.\",\n      \"method\": \"ChIP for H3K9 β-hydroxybutyrylation, transcriptome analysis, BDH1 KD/OE, LCN2 OE rescue, db/db mouse model, AAV-BDH1, NF-κB co-IP with RPS3\",\n      \"journal\": \"Cardiovascular diabetology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP for specific histone mark at LCN2 promoter + co-IP for NF-κB/RPS3 + in vivo AAV rescue, multiple orthogonal methods\",\n      \"pmids\": [\"40022118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FBXO2 binds LCN2 via its FBA domain and promotes K27-linked polyubiquitination of LCN2 to drive its proteasomal degradation, thereby suppressing LCN2-mediated ferroptosis; LCN2 silencing in FBXO2-deficient mice partially restores disc integrity.\",\n      \"method\": \"Proteomics, co-immunoprecipitation, ubiquitination assays, FBXO2 KO mice, AAV9-FBXO2 overexpression, LCN2 siRNA, in vivo IVDD model\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — co-IP + ubiquitination assay + domain mapping + in vivo genetic rescue, multiple orthogonal methods\",\n      \"pmids\": [\"40791152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LCN2 forms a ternary protein complex with LOXL2 and MMP9; LCN2-LOXL2 and LCN2-MMP9 interactions occur both intracellularly and extracellularly; the complex promotes cancer cell migration/invasion via upregulation of SPOCK1, FAK/AKT/GSK3β signaling, profilin 1, and filopodia formation.\",\n      \"method\": \"Protein-protein interaction assays (co-IP), in vitro migration/invasion, in vivo tumor models, deferoxamine (iron chelator) inhibition\",\n      \"journal\": \"Molecular oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP for ternary complex + functional cellular phenotypes + in vivo validation, single lab\",\n      \"pmids\": [\"37753805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"LCN2 binds iron-catecholate complexes (including enterobactin siderophores) within its lipocalin barrel binding pocket through a network of electrostatic interactions and hydrogen bonds, providing its bacteriostatic function by sequestering iron from bacteria.\",\n      \"method\": \"Computational modeling: B3LYP/6-311G(d,p) quantum calculations, flexible protein-ligand docking, Poisson-Boltzmann electrostatic analysis\",\n      \"journal\": \"Journal of molecular graphics & modelling\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational modeling only, no experimental validation in this paper\",\n      \"pmids\": [\"24018130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"IL-1β is a potent direct inducer of LCN2 in renal proximal tubular epithelial cells, with >30-fold mRNA increase; chronic IL-1β infusion in mice causes striking increases in plasma and kidney LCN2 protein levels independent of overt renal injury.\",\n      \"method\": \"In vivo IL-1β subcutaneous infusion, in vitro HK-2 and mpkCCD cell treatment, NGAL protein/mRNA quantification, immunohistochemistry\",\n      \"journal\": \"Cytokine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro concordant data with direct cytokine stimulation\",\n      \"pmids\": [\"27997859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Glucocorticoids and mineralocorticoids synergize with IL-1 to induce LCN2 expression in chondrogenic cells via glucocorticoid/mineralocorticoid receptors and the PI3K, ERK1/2, and JAK2 kinase pathways.\",\n      \"method\": \"RT-qPCR, Western blot, signaling pathway inhibitors, receptor agonists, ATDC5 chondrogenic cell line\",\n      \"journal\": \"Osteoarthritis and cartilage\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection of receptor and kinase requirements, single lab\",\n      \"pmids\": [\"28185846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TGF-β stimulates Smad2/3 binding to the PLEK2 promoter to induce PLEK2 expression, which in turn upregulates LCN2; LCN2 overexpression in PLEK2-knockdown cells rescues decreased migration and invasion; AKT phosphorylation is involved in this regulatory axis.\",\n      \"method\": \"Luciferase reporter assay, ChIP, RNA-seq, LCN2 overexpression rescue, PLEK2 knockdown, in vitro and in vivo functional assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + luciferase + RNA-seq + rescue experiments, single lab\",\n      \"pmids\": [\"34601488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Butyrate (produced by Faecalibacterium prausnitzii) reduces intracellular iron accumulation and suppresses ferroptosis in senescent cardiomyocytes by downregulating LCN2 expression.\",\n      \"method\": \"F. prausnitzii BCoAT mutant (butyrate-deficient), gene-editing, LCN2 measurement, ferroptosis assays, iron accumulation assays, aging rat model, fecal microbiota transplantation\",\n      \"journal\": \"Gut microbes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic butyrate-deficient mutant + in vivo model + mechanistic LCN2 link, single lab\",\n      \"pmids\": [\"40364435\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LCN2 (NGAL/24p3) is a secreted lipocalin that functions as an iron-transport protein (binding siderophores and catecholates to sequester iron from bacteria or deliver iron to cells via its receptor 24p3R/SLC22A17), forms a stabilizing complex with MMP-9 to sustain its proteolytic activity, induces or prevents apoptosis depending on its iron-loading status upon receptor-mediated internalization (iron-laden LCN2 is anti-apoptotic; apo-LCN2 promotes iron efflux and Bim-dependent apoptosis), suppresses ferroptosis by sequestering iron (regulated transcriptionally by NF-κB, STAT5, Foxo3a, MafG/MYH9, and epigenetically by H3K9 β-hydroxybutyrylation and H3K27 demethylation), modulates autophagy flux, binds EGFR to enhance its recycling and downstream MEK-ERK signaling, and is regulated by diverse upstream stimuli including TLR4, pro-inflammatory cytokines (IL-1β, TNF-α), hormones (estradiol via ERα), the JAK/STAT and Wnt pathways, and ubiquitin-proteasome degradation via FBXO2.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"LCN2 (NGAL) was isolated as a 25-kDa protein physically associated with human neutrophil gelatinase (MMP-9); immunoprecipitation and immunoblotting demonstrated that the 135-kDa form of gelatinase is a complex of 92-kDa gelatinase and NGAL, while the 220-kDa form is a homodimer of gelatinase alone. NGAL was identified as a member of the lipocalin family with one N-glycosylation site.\",\n      \"method\": \"Immunoprecipitation, immunoblotting, protein purification, primary structure determination, N-glycanase treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original isolation with multiple orthogonal biochemical methods; foundational paper with 978 citations\",\n      \"pmids\": [\"7683678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Mouse 24p3 protein (Lcn2) was identified as a member of the lipocalin protein family based on three conserved sequence motifs, proposing a ligand-binding function for small hydrophobic molecules.\",\n      \"method\": \"Computational sequence analysis using conserved lipocalin motifs\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational prediction only\",\n      \"pmids\": [\"1834059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The human NGAL gene was cloned and sequenced (5869 bp including 1695 bp of 5′ non-transcribed region, seven exons, six introns); transcriptional start sites were identified by RNase protection assay; the promoter contains binding sites for NF-κB, GATA-1, PU.1, and CTF/CBP, consistent with regulation in neutrophils and epithelial cells exposed to microorganisms.\",\n      \"method\": \"Gene cloning, sequencing, RNase protection assay, promoter analysis\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct cloning and transcriptional start site mapping with multiple methods\",\n      \"pmids\": [\"9339356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"LCN2 (24p3) is transcriptionally induced after IL-3 withdrawal in hematopoietic cells; conditioned medium containing secreted 24p3 induces apoptosis in naive IL-3-replete FL5.12 cells via an autocrine pathway; apoptotic sensitivity correlates with presence of a cell-surface receptor for 24p3; 24p3 induces apoptosis across a wide variety of leukocytes but not non-hematopoietic cells.\",\n      \"method\": \"DNA microarray, conditioned medium transfer, apoptosis assays, receptor-binding correlation\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (microarray, conditioned medium, receptor correlation); 311 citations; foundational mechanism paper\",\n      \"pmids\": [\"11486081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Megalin (LRP2), a member of the LDL receptor family expressed in polarized epithelia, binds NGAL with high affinity (demonstrated by surface plasmon resonance) and mediates its endocytosis in a megalin-antibody-blockable manner in rat yolk sac cells.\",\n      \"method\": \"Surface plasmon resonance, antibody-blocking endocytosis assay in BN16 cells\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding measurement plus functional cellular uptake assay; 283 citations\",\n      \"pmids\": [\"15670845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Ngal (LCN2) forms a complex with iron-binding siderophores (Ngal:siderophore:Fe) that is endocytosed by renal proximal tubule cells; this complex upregulates heme oxygenase-1, preserves N-cadherin, and inhibits cell death, protecting the kidney from ischemia-reperfusion injury; iron delivery is required since gallium (siderophore blockade) abolishes rescue; mouse urine contains an endogenous Ngal-dependent siderophore-like activity.\",\n      \"method\": \"Mouse ischemia-reperfusion model, single-dose protein rescue, gallium blockade, immunohistochemistry, in vivo iron delivery assay\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo rescue with mechanistic dissection (iron requirement, HO-1 induction, N-cadherin preservation); 756 citations\",\n      \"pmids\": [\"15711640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The 24p3 receptor (24p3R) internalizes iron-bound 24p3 to prevent apoptosis by delivering iron to cells, whereas the apo (iron-free) form of 24p3 induces cellular iron efflux and apoptosis through upregulation of the pro-apoptotic protein Bim.\",\n      \"method\": \"Receptor identification, iron-loaded vs. apo-protein internalization assays, Bim induction measurement\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection of receptor-mediated iron delivery vs. efflux; published in Cell; referenced in multiple independent papers\",\n      \"pmids\": [\"16377555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NGAL exerts bacteriostatic effects by capturing siderophores and depleting them of iron; eukaryotic siderophore-like molecules can bind NGAL to shuttle iron between extracellular and intracellular spaces; NGAL deficiency in mice leads to increased bacterial growth; NGAL acts as a growth and differentiation factor in renal epithelia, with activity enhanced by siderophore:iron complexes.\",\n      \"method\": \"NGAL-deficient mouse model (bacterial growth studies), cell culture differentiation assays, siderophore-binding assays\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus in vitro assays; comprehensive review synthesizing multiple experimental lines; 596 citations\",\n      \"pmids\": [\"17229907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"LPS-induced endotoxemia increases 24p3/Lcn2 expression in mouse lung and liver within 4 h via TLR-4 signaling; cells from C3H/HeJ mice with a nonfunctional TLR-4 show minimal 24p3 induction; NF-κB nuclear binding activity increases in alveolar macrophages and Type II cells; C/EBP activation occurs only in Type II cells, indicating differential transcription factor usage.\",\n      \"method\": \"In vivo LPS administration, RT-PCR, Western blot, immunohistochemistry, TLR-4 mutant mice, NF-κB and C/EBP EMSA\",\n      \"journal\": \"Experimental and molecular pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic model (TLR-4 mutant) plus transcription factor assays; single study\",\n      \"pmids\": [\"17490638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"24p3 is a direct transcriptional target of Foxo3a; PI3K/Akt (but not MAPK) mediates IL-3-repressed 24p3 expression by phosphorylating and inactivating Foxo3a; constitutively active Akt attenuates 24p3 expression and apoptosis after IL-3 withdrawal; Foxo3a binds directly to the 24p3 promoter and induces its activity.\",\n      \"method\": \"Promoter reporter assay, ChIP (Foxo3a binding to 24p3 promoter), constitutively active Akt overexpression, PI3K/MAPK inhibitors, FL5.12 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct promoter binding (ChIP), epistasis with constitutively active Akt, multiple inhibitor approaches\",\n      \"pmids\": [\"19056725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BCR-ABL upregulates 24p3 expression via the JAK/STAT pathway (Stat5 binds the 24p3 promoter), while simultaneously repressing 24p3R expression by switching Runx3 (activator) to Runx1 (repressor) binding through a Ras signaling pathway; this asymmetry allows BCR-ABL+ cells to secrete apoptosis-inducing 24p3 that kills normal cells expressing 24p3R but not BCR-ABL+ cells themselves; repression of 24p3R is required for imatinib to kill BCR-ABL+ cells.\",\n      \"method\": \"ChIP (Stat5 binding to 24p3 promoter; Runx1/3 binding to 24p3R promoter), signaling pathway inhibitors, imatinib kill assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP with mechanistic epistasis across two pathways; functional consequence in drug sensitivity validated\",\n      \"pmids\": [\"19229297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"IL-17 induces 24p3/lipocalin-2 transcription primarily through two essential promoter elements: NF-κB and C/EBP binding sites; deletion of either site eliminates promoter activity; IL-17 synergizes with TNF-α at the promoter level. NF-κB and C/EBP sites are statistically over-represented in IL-17 target gene promoters.\",\n      \"method\": \"Promoter deletion/reporter assays, TFBS computational analysis across 18 IL-17 target genes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — promoter deletion mapping with functional validation plus bioinformatics confirmation; 250 citations\",\n      \"pmids\": [\"16798734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Lcn2 promotes breast cancer epithelial-to-mesenchymal transition (EMT) by upregulating mesenchymal markers (vimentin, fibronectin), downregulating E-cadherin, and increasing cell motility and invasiveness; this occurs through suppression of ERα and induction of the EMT transcription factor Slug; ERα overexpression reverses Lcn2-induced EMT; in orthotopic models, Lcn2-expressing tumors show increased local invasion and lymph node metastasis.\",\n      \"method\": \"Lcn2 overexpression/silencing in breast cancer cells, EMT marker immunoblotting, motility/invasion assays, ERα rescue, orthotopic mouse model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function and loss-of-function with defined molecular pathway (ERα/Slug axis) and in vivo validation; 309 citations\",\n      \"pmids\": [\"19237579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Lcn2 is an active driver of chronic kidney disease (CKD) progression: Lcn2-/- mice show dramatically reduced renal lesion severity after nephron reduction; Lcn2 expression is induced by EGFR activation; HIF-1α is required for EGFR-induced Lcn2 overexpression; Lcn2 mediates the mitogenic effect of EGFR during renal deterioration (cell proliferation markedly reduced in Lcn2-/- mice); EGFR inhibition prevents Lcn2 upregulation.\",\n      \"method\": \"Lcn2 knockout mice (nephron reduction model), EGFR dominant-negative transgenic mice, HIF-1α requirement assessed, genome-wide expression profiling, EGFR inhibitor treatment\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with mechanistic epistasis (EGFR→HIF-1α→Lcn2 pathway), multiple genetic and pharmacological approaches; 320 citations\",\n      \"pmids\": [\"20921623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"24p3-null mice accumulate lymphoid, myeloid, and erythroid cells due to apoptotic defects in mature hematopoietic cell types (neutrophils, mast cells, thymocytes, erythroid cells); Bim induction in response to apoptotic stimuli is attenuated in 24p3-/- cells, explaining their resistance to cell death; competitive repopulation shows no enhanced hematopoiesis, confirming a survival rather than proliferation defect.\",\n      \"method\": \"24p3 null mice (C57BL/6 and 129/SVE backgrounds), competitive repopulation, myelosuppression recovery, apoptosis assays, Bim Western blotting, dexamethasone-induced thymocyte apoptosis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic KO with defined molecular effector (Bim) across multiple hematopoietic lineages\",\n      \"pmids\": [\"21507940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"S2R(Pgrmc1) regulates NGAL/LCN2 expression at the mRNA and protein levels; S2R knockdown decreases MMP-9 activity, and NGAL is required for MMP-9 activity and tumor formation; S2R associates with EGFR to increase EGFR membrane levels, and EGFR/Akt/ERK inhibitors suppress NGAL expression; LCN2 is transcriptionally regulated by NF-κB, and S2R knockdown reduces p65/RelA acetylation and phosphorylation; HDAC1 inhibitors restore p65 acetylation and partially restore NGAL levels.\",\n      \"method\": \"Antibody array screening, siRNA knockdown, RT-PCR, Western blot, gelatin zymography, EGFR/Akt/ERK inhibitors, NF-κB activation assays, HDAC inhibitors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibitor approaches and knockdown with pathway placement; single study\",\n      \"pmids\": [\"22418433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"24p3-deficient neutrophils are defective in extravasation to infection sites, chemotaxis, and phagocytosis of bacteria; transcriptome analysis shows selective suppression of genes controlling cytoskeletal reorganization, and microRNAs regulating upstream cytoskeletal proteins are increased in 24p3-/- neutrophils; 24p3-/- mice show enhanced susceptibility to Listeria, Candida, and Staphylococcus, which is not attributable to siderophore sequestration.\",\n      \"method\": \"24p3-/- mice, in vivo infection models, neutrophil chemotaxis assays, phagocytosis assays, transcriptome analysis, microRNA profiling\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple cellular functional readouts and transcriptomic mechanism; non-siderophore mechanism established\",\n      \"pmids\": [\"23543755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The 24p3 receptor (24p3R/SLC22A17) mediates albumin endocytosis in cortical collecting duct cells and activates NF-κB and TGF-β1 signaling in response to luminal albumin, leading to upregulation of profibrotic markers (Snail, vimentin) via an autocrine mechanism.\",\n      \"method\": \"FITC-albumin uptake assay, NF-κB luciferase reporter, NF-κB p65 nuclear translocation, target gene expression, 24p3R siRNA knockdown in mCCDcl1 cells, in vivo PAN nephrotic rat model\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor knockdown with defined signaling readouts; in vitro and in vivo correlation\",\n      \"pmids\": [\"23884139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LCN2 regulates hepatic lipid droplet formation by controlling expression of the lipid droplet coat protein PLIN5 (Perilipin 5/OXPAT); Lcn2-/- mice fed MCD diet accumulate more hepatic lipids with reduced basal PLIN5; restoration of LCN2 in Lcn2-/- primary hepatocytes by transfection or adenoviral infection restores PLIN5 expression and proper lipid droplet formation.\",\n      \"method\": \"Lcn2-/- mice, MCD and high-fat diet models, adenoviral LCN2 reconstitution, PLIN5 Western blot and IHC, lipid accumulation quantification in vitro and in vivo\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus reconstitution (adenoviral) with defined molecular target (PLIN5)\",\n      \"pmids\": [\"25086218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Glucocorticoids and mineralocorticoids synergize with IL-1 to induce LCN2 expression in chondrogenic cells; this effect requires glucocorticoid or mineralocorticoid receptors and is mediated through PI3K, ERK1/2, and JAK2 kinases.\",\n      \"method\": \"ATDC5 chondrogenic cell line, RT-qPCR, Western blot, signaling pathway inhibitors (PI3K, ERK1/2, JAK2), corticoid receptor antagonists\",\n      \"journal\": \"Osteoarthritis and cartilage\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibitors defining pathway; single study, single cell line\",\n      \"pmids\": [\"28185846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LCN2 attenuates autophagy to exacerbate cardiac apoptosis during ischemia: Lcn2-KO mice show greater ischemia-induced autophagy (LC3/p62 Western blot, LC3 IHC, TEM) and are protected from ischemia-induced caspase-3 activation and cardiac dysfunction; exogenous Lcn2 treatment of cardiomyocytes suppresses autophagic flux (AMPK/ULK1 phosphorylation, tandem RFP/GFP-LC3, cathepsin activity), and exacerbates hypoxia-induced cytochrome c release and caspase-3 activation; autophagy-deficient (dominant-negative Atg5) cells show increased apoptosis with Lcn2 treatment.\",\n      \"method\": \"Lcn2-KO mice (coronary ligation), echocardiography, Western blot (LC3, p62, AMPK, ULK1), TEM, tandem fluorescent LC3 assay, lysosomal cathepsin assay, DN-Atg5 overexpression\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus gain-of-function with multiple orthogonal autophagy readouts and defined epistasis with Atg5\",\n      \"pmids\": [\"27800610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Tumor-associated macrophages (TAMs) secrete LCN2 to deliver iron to tumor cells; LCN2-neutralizing antibody restores intracellular iron to pre-TAM levels, establishing LCN2 as an iron transporter between macrophages and tumor cells in the microenvironment.\",\n      \"method\": \"TAM co-culture, LCN2 ELISA, intracellular iron measurement, LCN2-neutralizing antibody, tumor cell iron assays\",\n      \"journal\": \"International journal of physiology, pathophysiology and pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single-lab study with antibody neutralization; iron transport function demonstrated functionally\",\n      \"pmids\": [\"29755643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss of LIFR in hepatocytes activates NF-κB signaling through SHP1, leading to upregulation of LCN2; LCN2 sequesters iron and confers resistance to ferroptosis inducers; an LCN2-neutralizing antibody enhances ferroptosis-inducing and anticancer effects of sorafenib on HCC patient-derived xenograft tumors with low LIFR/high LCN2.\",\n      \"method\": \"Hepatocyte-specific and inducible Lifr-KO mice, NF-κB pathway analysis, LCN2 expression measurement, ferroptosis assays (lipid peroxidation, cell death), LCN2-neutralizing antibody in PDX tumor model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with mechanistic pathway (LIFR→SHP1→NF-κB→LCN2→ferroptosis resistance) and therapeutic validation in PDX\",\n      \"pmids\": [\"34921145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NOX (NADPH oxidase)-NF-κB signaling in reactive astrocytes drives LCN2 expression and secretion after stroke; astrocyte-specific NHE1 deletion reduces astrogliosis and LCN2/GFAP expression, decreasing neuronal loss; ischemia triggers LCN2-containing exosome secretion from astrocytes that causes neuronal death; NHE1 inhibitor (HOE642) reduces LCN2+ exosome secretion; LCN2-mediated neuronal apoptosis and neurite degeneration are attenuated by NHE1 inhibition.\",\n      \"method\": \"Astrocyte-specific Nhe1 conditional KO mice (stroke model), in vitro ischemia in astrocyte cultures, exosome isolation and characterization, Western blot, NOX/NF-κB inhibitors, neuronal viability assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic astrocyte-specific KO with mechanistic pathway (NHE1→NOX→NF-κB→LCN2) and functional neuronal death readout\",\n      \"pmids\": [\"35440572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Glioma-derived exosomes upregulate LCN2 in brain microvascular endothelial cells via the JAK-STAT3 pathway (LCN2 is not delivered from exosomes but induced in recipient cells); LCN2 upregulation increases membrane fluidity of endothelial cells, facilitating nanocapsule crossing of the blood-brain barrier; LCN2 knockdown in endothelial cells abrogates the exosome-induced membrane fluidity effect.\",\n      \"method\": \"Tandem mass tag proteomics, JAK-STAT3 pathway inhibitors, LCN2 siRNA knockdown, membrane fluidity assay, in vivo nanocapsule BBB crossing (IP and IV injection)\",\n      \"journal\": \"Journal of controlled release\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — proteomics plus siRNA knockdown with defined pathway and functional BBB permeability readout; single study\",\n      \"pmids\": [\"35341902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LCN2 secretion from reactive astrocytes can be reduced by two mechanisms: (1) proteasome inhibition suppresses NF-κB activation through IκBα stabilization, downregulating Lcn2 expression; (2) autophagic flux activation via mTOR inhibition degrades intracellular LCN2 pre-secretorily; the N-terminal signal peptide of LCN2 is critical for both its secretion and pre-secretory autophagic degradation; reducing secreted LCN2 by either mechanism increases neuronal viability under inflammatory stress.\",\n      \"method\": \"LPS-stimulated primary astrocytes, proteasome inhibitor (bortezomib), mTOR inhibitor, IκBα Western blot, autophagy flux assays (LC3/SQSTM1), LCN2 signal peptide deletion mutants, neuronal viability assays in conditioned medium\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — two mechanistically distinct pathways both validated with defined molecular intermediates and functional neuronal readout\",\n      \"pmids\": [\"36781380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Tissue-infiltrating neutrophils (TI-Neu) are the primary source of LCN2 in lung cancer cachexia; LCN2 secreted by TI-Neu induces ferroptosis in adipose and muscle tissues, causing wasting; antibody depletion of TI-Neu and myeloid-specific Lcn2 knockout both prevent ferroptosis and tissue wasting; chemical inhibition of ferroptosis alleviates tissue wasting and prolongs survival.\",\n      \"method\": \"Lung cancer mouse models, LCN2 blockade/overexpression, antibody depletion of neutrophils, myeloid-specific Lcn2 KO (LysM-Cre), ferroptosis inhibitor (ferrostatin), tissue iron/lipid peroxidation assays\",\n      \"journal\": \"Journal of hematology & oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO plus antibody depletion defining LCN2 source; ferroptosis mechanism validated pharmacologically\",\n      \"pmids\": [\"36973755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LCN2 binds SLC3A2 (system Xc- heavy chain) and inhibits downstream glutathione synthesis and GPX4 expression, promoting ferroptosis after intracerebral hemorrhage; this interaction was validated by molecular docking and co-immunoprecipitation.\",\n      \"method\": \"Co-immunoprecipitation, molecular docking, proteomics, LCN2 overexpression/rescue experiments, GSH and GPX4 measurement in brain tissue\",\n      \"journal\": \"Phytomedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — co-IP binding plus functional ferroptosis readout; single study with pharmacological intervention\",\n      \"pmids\": [\"37130481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LCN2 binds EGFR and enhances EGFR recycling back to the plasma membrane, thereby activating the EGFR-MEK-ERK cascade in oral squamous cell carcinoma; LCN2 inhibition reduces EGFR phosphorylation and downstream signaling, suppressing proliferation and metastasis.\",\n      \"method\": \"Mass spectrometry, co-IP, immunoblotting, immunofluorescence, EGFR recycling assays, siRNA knockdown, in vivo xenograft and PDX models\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS-identified interaction validated by co-IP, receptor recycling mechanistically demonstrated, and rescued in vivo\",\n      \"pmids\": [\"36899380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Increased LCN2 in reactive astrocytes suppresses neurogenesis; anti-neurogenic effects of LCN2 are mediated by SLC22A17 (24p3R); Ngfr expression reduces reactive astrocyte LCN2, and SLC22A17 blockade recapitulates the pro-neurogenic effect; LCN2/SLC22A17 axis downstream of NGFR signaling modulates astrocyte fate in Alzheimer's disease.\",\n      \"method\": \"APP/PS1dE9 mouse model, AAV-Ngfr hippocampal injection, single-cell transcriptomics, spatial proteomics, SLC22A17 functional knockdown, neurogenesis histology, 3D human astroglial cultures\",\n      \"journal\": \"NPJ Regenerative medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic manipulation with single-cell transcriptomics; SLC22A17 knockdown epistasis; single study\",\n      \"pmids\": [\"37429840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LCN2 forms a ternary complex with LOXL2 and MMP9; LCN2-LOXL2 and LCN2-MMP9 interactions occur both intracellularly and extracellularly, while LOXL2-MMP9 interaction is only intracellular; the LCN2/LOXL2/MMP9 complex promotes ECM degradation (fibronectin, Matrigel), filopodia formation, microfilament rearrangement via profilin-1 upregulation, and activates FAK/AKT/GSK3β signaling to drive ESCC metastasis.\",\n      \"method\": \"Co-IP (protein-protein interaction assays), co-overexpression, ECM degradation assays, filopodia/actin imaging, SPOCK1 and FAK/AKT/GSK3β pathway Western blots, in vivo tumor growth and metastasis\",\n      \"journal\": \"Molecular oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — co-IP defines trimeric complex with intracellular/extracellular localization distinction; downstream pathway and functional assays; single study\",\n      \"pmids\": [\"37753805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MafG physically interacts with MYH9 (non-muscle myosin heavy chain IIa) and the MafG/MYH9 complex transcriptionally activates LCN2 via a MARE motif in the LCN2 promoter; site-directed mutation of the MARE motif blocks MafG binding and LCN2 transcription; LCN2 re-expression in MafG-knockdown HSCs restores resistance to ferroptosis, thereby promoting liver fibrosis.\",\n      \"method\": \"Co-IP (MafG-MYH9 interaction), MARE motif site-directed mutagenesis, LCN2 promoter reporter assay, LCN2 reconstitution in MafG-KD cells, BDL mouse model, AAV6 HSC-specific MafG knockdown, ferroptosis assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — protein interaction (co-IP), promoter mutagenesis, reconstitution rescue, and in vivo genetic validation\",\n      \"pmids\": [\"38871948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BDH1 overexpression reprograms ketone metabolism, increasing AcAc and decreasing β-OHB, which reduces β-hydroxybutyrylation of H3K9 (H3K9bhb) at the LCN2 promoter, repressing LCN2 transcription; decreased LCN2 in turn weakens NF-κB-RPS3 interaction, reducing NF-κB activity and cardiac injury; LCN2 overexpression reverses BDH1-mediated myocardial protection.\",\n      \"method\": \"BDH1 KO and AAV-BDH1 overexpression in db/db mice, ChIP (H3K9bhb at LCN2 promoter), H3K9bhb inhibitor (A485), NF-κB/RPS3 co-IP, LCN2 overexpression rescue, transcriptome analysis\",\n      \"journal\": \"Cardiovascular diabetology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — histone modification ChIP at LCN2 promoter, protein interaction (NF-κB/RPS3), genetic KO/OE with rescue; multiple orthogonal methods\",\n      \"pmids\": [\"40022118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FBXO2 binds LCN2 via its FBA domain and promotes K27-linked polyubiquitination of LCN2, driving its proteasomal degradation; FBXO2 co-expression reverses LCN2-induced mitochondrial dysfunction and ferroptosis; LCN2 silencing in FBXO2-deficient mice partially restores disc integrity in intervertebral disc degeneration.\",\n      \"method\": \"Proteomics, co-IP (FBXO2-LCN2 via FBA domain), ubiquitination assay (K27-linked), proteasome inhibitor rescue, LCN2 KD in FBXO2-KO mice, ferroptosis markers\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical ubiquitination assay with lysine-linkage specificity, co-IP, domain mapping, and genetic validation in vivo\",\n      \"pmids\": [\"40791152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ROS induces STAT3-mediated MVP transcription; PGAM5 dephosphorylates MVP at S873, enabling MVP to bind LCN2 mRNA and stabilize it, thereby suppressing ferroptosis (reducing lipid peroxidation and intracellular Fe2+) and conferring sorafenib resistance in HCC; disrupting MVP-LCN2 mRNA interaction with tenapanor enhances ferroptosis and sorafenib sensitivity.\",\n      \"method\": \"RBP screening, MVP-LCN2 mRNA binding assay, PGAM5 dephosphorylation assay (S873 phosphorylation site), LCN2 mRNA stability measurement, ferroptosis assays, tenapanor pharmacological inhibition, HCC cell and in vivo models\",\n      \"journal\": \"Drug resistance updates\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical dephosphorylation site mapping plus mRNA stabilization mechanism; single study\",\n      \"pmids\": [\"40262414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Computational modeling (B3LYP DFT calculations + protein-ligand docking) demonstrates that NGAL binds Fe(III)-catecholate complexes (mono-, bis-, tris-catecholate) within its lipocalin binding pocket through a network of hydrogen bonds and electrostatic interactions, providing a structural basis for iron-catecholate binding beyond the known enterobactin interaction.\",\n      \"method\": \"B3LYP/6-311G(d,p) quantum calculations, protein-ligand flexible docking, Poisson-Boltzmann electrostatic analysis\",\n      \"journal\": \"Journal of molecular graphics & modelling\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational modeling only, no experimental validation\",\n      \"pmids\": [\"24018130\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LCN2 (NGAL/24p3) is a secreted lipocalin that functions as an iron-trafficking protein—binding bacterial siderophores to exert bacteriostatic effects and shuttling iron into or out of cells via its receptor (SLC22A17/24p3R) or megalin to modulate apoptosis (iron-loaded form is pro-survival; apo-form depletes iron and activates Bim-dependent apoptosis)—while also forming a stabilizing complex with MMP-9, serving as a direct transcriptional target of NF-κB, C/EBP, Stat5, and Foxo3a (downstream of IL-17, BCR-ABL, PI3K/Akt, and EGFR/HIF-1α signaling), promoting EMT via the ERα/Slug axis, suppressing autophagic flux to enhance ischemia-induced apoptosis, regulating hepatic lipid droplet formation through PLIN5, driving ferroptosis resistance by sequestering iron (regulated epigenetically by H3K9bhb and by FBXO2-mediated K27-ubiquitination for degradation), and modulating neuroinflammation through astrocytic exosome secretion downstream of NOX-NF-κB and NHE1 signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"LCN2 (also known as NGAL/24p3) is a secreted lipocalin that functions as an iron-trafficking protein and pleiotropic mediator of cell survival, innate immunity, and tissue remodeling. LCN2 binds iron-siderophore complexes and, upon receptor (24p3R/SLC22A17)-mediated internalization, exerts context-dependent effects on cell fate: iron-loaded (holo) LCN2 promotes cell survival, whereas iron-free (apo) LCN2 triggers iron efflux and Bim-dependent apoptosis, as demonstrated by receptor internalization studies and confirmed in LCN2-knockout mice showing defective hematopoietic apoptosis and impaired neutrophil function [PMID:16377555, PMID:21507940, PMID:23543755]. LCN2 physically associates with MMP-9 to protect it from autodegradation and sustains its proteolytic activity, forms a ternary complex with LOXL2 and MMP-9 to promote invasion, binds EGFR to enhance its recycling and MEK-ERK signaling, and interacts with SLC3A2 to inhibit glutathione synthesis and GPX4 expression, thereby modulating ferroptosis [PMID:7683678, PMID:36899380, PMID:37130481, PMID:37753805]. LCN2 transcription is activated by NF-κB (downstream of TLR4, EGFR, and NOX signaling), STAT5, Foxo3a, MafG/MYH9 at MARE motifs, and H3K27 demethylation by Kdm6a, while it is repressed by E2F6 and epigenetically silenced by loss of H3K9 β-hydroxybutyrylation; at the protein level, FBXO2 targets LCN2 for K27-linked polyubiquitination and proteasomal degradation [PMID:19056725, PMID:19229297, PMID:38871948, PMID:35995279, PMID:40022118, PMID:40791152].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Identification of LCN2 as a neutrophil-derived lipocalin physically complexed with MMP-9 established its dual identity as both a lipocalin-family member and a regulator of extracellular matrix proteolysis.\",\n      \"evidence\": \"Immunoprecipitation, immunoblotting, and N-terminal sequencing from human neutrophil extracts\",\n      \"pmids\": [\"7683678\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No ligand for the lipocalin barrel was identified\",\n        \"Functional consequence of MMP-9 association for proteolytic activity not yet tested\",\n        \"Whether LCN2 acts independently of MMP-9 was unknown\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery of the LCN2 receptor (24p3R) and demonstration that iron-loading status dictates whether internalized LCN2 triggers apoptosis or survival resolved how a single secreted protein could have opposing effects on cell fate.\",\n      \"evidence\": \"Receptor identification, iron-loaded vs. apo-LCN2 internalization, Bim-dependent apoptosis assays in cultured cells\",\n      \"pmids\": [\"16377555\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of iron-siderophore binding within the LCN2 barrel not experimentally resolved\",\n        \"Whether the 24p3R-mediated pathway operates in all cell types was unclear\",\n        \"Identity of the endogenous siderophore/catecholate ligand in mammals remained uncertain\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Multiple upstream pathways converging on LCN2 transcription were mapped, including TLR4/NF-κB in innate immunity and Wnt-dependent regulation independent of iron, establishing LCN2 as a signal-integrating node.\",\n      \"evidence\": \"TLR4-mutant mice with LPS challenge showing NF-κB-dependent LCN2 induction; Wnt pathway activation/iron manipulation in cultured cells\",\n      \"pmids\": [\"17490638\", \"17350462\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether NF-κB binds the LCN2 promoter directly was not shown by ChIP in these studies\",\n        \"Relative contribution of Wnt vs. NF-κB in physiological contexts not determined\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Direct transcriptional control of LCN2 by Foxo3a downstream of PI3K/Akt linked growth factor signaling to the pro-apoptotic LCN2 axis, explaining how IL-3 withdrawal derepresses LCN2.\",\n      \"evidence\": \"Promoter reporter assays, constitutively active Akt, Foxo3a chromatin binding in hematopoietic cells\",\n      \"pmids\": [\"19056725\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Foxo3a cooperates with NF-κB at the LCN2 promoter was untested\",\n        \"In vivo validation of Foxo3a-LCN2 axis was lacking\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"STAT5 was identified as a direct transcriptional activator of LCN2 downstream of BCR-ABL/JAK, while Ras-driven Runx1/Runx3 switching represses the receptor 24p3R, revealing how oncogenic signaling co-opts the LCN2 system to evade apoptosis.\",\n      \"evidence\": \"ChIP for STAT5 at 24p3 promoter and Runx1/Runx3 at 24p3R promoter; imatinib functional assays in BCR-ABL+ cells\",\n      \"pmids\": [\"19229297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether STAT5-driven LCN2 upregulation occurs in non-BCR-ABL contexts was not examined\",\n        \"Mechanism by which Ras switches Runx3→Runx1 occupancy was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"LCN2-knockout mice demonstrated an in vivo requirement for LCN2 in hematopoietic homeostasis through Bim-dependent apoptosis, validating the cell-autonomous pro-apoptotic function first shown in vitro.\",\n      \"evidence\": \"24p3-/- knockout mice with competitive repopulation, apoptosis assays, and Bim Western blot across multiple lineages\",\n      \"pmids\": [\"21507940\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Iron-loading status of LCN2 in vivo was not directly measured\",\n        \"Whether receptor 24p3R is required for the in vivo phenotype was not tested genetically\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"LCN2-knockout mice revealed a broader innate immune role: LCN2 is required for neutrophil extravasation, chemotaxis, and bacterial phagocytosis, linked mechanistically to regulation of cytoskeletal gene expression and microRNA networks.\",\n      \"evidence\": \"24p3-/- mice with infection models, chemotaxis/phagocytosis assays, transcriptome and microRNA profiling\",\n      \"pmids\": [\"23543755\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether cytoskeletal defects are iron-dependent or iron-independent was not resolved\",\n        \"Specific microRNA targets mediating the phenotype were not individually validated\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that LCN2 controls hepatic lipid droplet formation through PLIN5 upregulation expanded its metabolic roles beyond iron transport to lipid homeostasis.\",\n      \"evidence\": \"Lcn2-knockout mice on MCD diet, adenoviral LCN2 rescue restoring PLIN5 and lipid droplet formation in hepatocytes\",\n      \"pmids\": [\"25086218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether LCN2 acts on PLIN5 transcription directly or indirectly was not determined\",\n        \"Whether this lipid function requires iron binding or 24p3R was untested\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"LCN2 was shown to suppress protective autophagy in cardiomyocytes during ischemia, establishing it as a negative regulator of autophagic flux that exacerbates ischemic injury.\",\n      \"evidence\": \"Coronary artery ligation in Lcn2-KO mice with echocardiography, LC3/p62 quantification, tandem fluorescence autophagy assays, AMPK/ULK1 signaling\",\n      \"pmids\": [\"27800610\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct molecular target through which LCN2 inhibits autophagy initiation was not identified\",\n        \"Whether autophagy suppression is iron-dependent was not tested\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"LCN2 was established as a suppressor of ferroptosis through iron depletion downstream of NF-κB, conferring resistance to ferroptosis inducers and sorafenib in hepatocellular carcinoma.\",\n      \"evidence\": \"Hepatocyte-specific Lifr-KO mice, NF-κB signaling, LCN2 neutralizing antibody restoring sorafenib sensitivity in PDX models\",\n      \"pmids\": [\"34921145\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether LCN2-mediated iron sequestration is the sole mechanism of ferroptosis resistance was not fully excluded\",\n        \"Direct measurement of labile iron pool changes upon LCN2 neutralization was limited\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Epigenetic regulation of LCN2 was revealed through H3K27 demethylation by Kdm6a in microglia/macrophages, and astrocytic NOX-NF-κB signaling was shown to drive LCN2 secretion via exosomes causing neuronal death, broadening understanding of LCN2's roles in neurodegeneration and diabetic retinopathy.\",\n      \"evidence\": \"Conditional Kdm6a-KO mice with RNA-seq; astrocyte-specific Nhe1-KO mice, stroke model, LCN2 exosome quantification\",\n      \"pmids\": [\"35995279\", \"35440572\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Kdm6a acts directly at the LCN2 promoter or through intermediate transcription factors was not fully resolved\",\n        \"Exosomal vs. free LCN2 contributions to neurotoxicity were not quantitatively separated\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"LCN2 was found to bind EGFR and enhance its recycling to the plasma membrane, activating MEK-ERK signaling, and separately to interact with SLC3A2 to inhibit glutathione synthesis and GPX4, providing two new direct protein interaction mechanisms—one promoting proliferation and the other promoting ferroptosis.\",\n      \"evidence\": \"Co-IP and mass spectrometry for LCN2-EGFR; co-IP and molecular docking for LCN2-SLC3A2; EGFR recycling assays; in vivo siRNA delivery\",\n      \"pmids\": [\"36899380\", \"37130481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of LCN2-EGFR and LCN2-SLC3A2 interactions not resolved crystallographically\",\n        \"Whether EGFR binding and SLC3A2 binding are mutually exclusive or concurrent is unknown\",\n        \"LCN2-SLC3A2 interaction awaits independent confirmation\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"MafG/MYH9 complex was identified as a direct transcriptional activator binding the MARE motif in the LCN2 promoter, and H3K9 β-hydroxybutyrylation was shown to epigenetically activate LCN2, connecting metabolic (ketone body) and transcriptional programs to LCN2-dependent ferroptosis suppression and NF-κB enhancement.\",\n      \"evidence\": \"ChIP for MafG at LCN2 MARE motif with site-directed mutagenesis; ChIP for H3K9bhb at LCN2 promoter; BDH1 overexpression/KD; co-IP showing LCN2 strengthens NF-κB/RPS3 interaction\",\n      \"pmids\": [\"38871948\", \"40022118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How MYH9 (a myosin) cooperates with MafG at chromatin mechanistically is unclear\",\n        \"Whether H3K9bhb and MafG act at the same or distinct promoter regions was not tested\",\n        \"In vivo validation of the BDH1-H3K9bhb-LCN2 axis in tissues beyond heart was lacking\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"FBXO2 was identified as the E3 ligase targeting LCN2 for K27-linked polyubiquitination and proteasomal degradation, establishing the first defined mechanism for LCN2 protein turnover.\",\n      \"evidence\": \"Co-IP, ubiquitination assays with K27-linkage specificity, FBXO2-KO mice, AAV9-FBXO2 overexpression, LCN2 siRNA rescue in intervertebral disc degeneration model\",\n      \"pmids\": [\"40791152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether FBXO2-mediated degradation operates in immune cells or only in disc tissue is untested\",\n        \"Lysine residue(s) on LCN2 targeted by FBXO2 were not mapped\",\n        \"Whether other E3 ligases also target LCN2 is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the endogenous mammalian siderophore/catecholate carried by LCN2, the structural basis of LCN2 interactions with EGFR and SLC3A2, the molecular mechanism by which LCN2 suppresses autophagic flux, and whether the pro-ferroptotic versus anti-ferroptotic activities of LCN2 are determined by iron-loading status or by distinct protein interaction partners in different cellular contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Endogenous mammalian LCN2 ligand remains unidentified\",\n        \"No crystal structure of LCN2 in complex with EGFR, SLC3A2, or 24p3R\",\n        \"Mechanism by which LCN2 inhibits autophagy initiation not molecularly defined\",\n        \"Context rules determining pro- vs. anti-ferroptotic LCN2 activity not systematically resolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [1, 36]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [2, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 5, 26, 29]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 18, 23, 25, 28]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 14, 19, 23]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 3, 6, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 10, 13, 21, 26, 33]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [16, 24]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [17, 27]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [11, 21, 28, 31]}\n    ],\n    \"complexes\": [\n      \"LCN2/MMP-9 heterodimer\",\n      \"LCN2/LOXL2/MMP-9 ternary complex\",\n      \"MafG/MYH9 transcriptional complex (upstream)\"\n    ],\n    \"partners\": [\n      \"MMP9\",\n      \"SLC22A17\",\n      \"EGFR\",\n      \"SLC3A2\",\n      \"LOXL2\",\n      \"FBXO2\",\n      \"MYH9\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"LCN2 (NGAL/24p3) is a secreted lipocalin that functions as an iron-trafficking protein central to innate immunity, cell survival decisions, and ferroptosis regulation. It captures bacterial siderophores to restrict iron availability during infection and shuttles iron into or out of cells via its receptors SLC22A17 (24p3R) and megalin: iron-loaded LCN2 promotes cell survival, whereas apo-LCN2 induces iron efflux and Bim-dependent apoptosis [PMID:16377555, PMID:15711640, PMID:21507940]. LCN2 is transcriptionally activated by NF-κB, C/EBP, Foxo3a, Stat5, and HIF-1α downstream of diverse signals including IL-17, BCR-ABL, EGFR, and TLR4, and is epigenetically regulated by H3K9 β-hydroxybutyrylation and post-translationally targeted for FBXO2-mediated K27-linked ubiquitination and proteasomal degradation [PMID:16798734, PMID:19056725, PMID:40022118, PMID:40791152]. Beyond iron sequestration, LCN2 stabilizes MMP-9, promotes epithelial-to-mesenchymal transition through ERα/Slug suppression, attenuates protective autophagy in ischemic cardiomyocytes, drives ferroptosis in cachexia-associated tissues, confers ferroptosis resistance in hepatocellular carcinoma and hepatic stellate cells, and mediates neuroinflammatory injury through astrocytic exosome secretion [PMID:7683678, PMID:19237579, PMID:27800610, PMID:36973755, PMID:34921145, PMID:35440572].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Identification of LCN2 as a lipocalin physically complexed with MMP-9 in neutrophils established the gene product and its first known protein partner, raising the question of what ligand this lipocalin binds and what biological function the NGAL–MMP-9 complex serves.\",\n      \"evidence\": \"Immunoprecipitation and protein purification from human neutrophils\",\n      \"pmids\": [\"7683678\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The physiological ligand of the lipocalin pocket was unknown\", \"Whether NGAL modulates MMP-9 enzymatic activity or merely stabilizes it was not resolved\", \"Function beyond neutrophils was unexplored\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovery that secreted 24p3/LCN2 induces apoptosis in hematopoietic cells via an autocrine mechanism linked to a specific cell-surface receptor revealed the protein as a cytokine-like effector of cell death, not merely a structural lipocalin.\",\n      \"evidence\": \"DNA microarray after IL-3 withdrawal, conditioned medium transfer apoptosis assays in FL5.12 cells\",\n      \"pmids\": [\"11486081\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The receptor identity was unknown\", \"The role of iron in apoptosis induction was not yet established\", \"Whether LCN2-mediated apoptosis operates in non-hematopoietic cells was unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Three studies converged to establish LCN2 as a siderophore-dependent iron transporter with two distinct receptors (megalin and 24p3R/SLC22A17) and opposing biological outcomes depending on iron loading: holo-LCN2 delivers iron and promotes survival, while apo-LCN2 depletes intracellular iron and triggers Bim-dependent apoptosis.\",\n      \"evidence\": \"Surface plasmon resonance for megalin binding; in vivo kidney ischemia-reperfusion rescue with gallium blockade; receptor identification with iron-loaded vs. apo-protein internalization and Bim induction assays\",\n      \"pmids\": [\"15670845\", \"15711640\", \"16377555\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The identity of endogenous mammalian siderophores remained uncertain\", \"How 24p3R mediates iron efflux mechanistically was unresolved\", \"Whether megalin and 24p3R have tissue-specific or redundant roles was not clarified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Mapping of the LCN2 promoter identified NF-κB and C/EBP as essential transcriptional drivers downstream of IL-17/TNFα, and subsequent studies placed Foxo3a (repressed by PI3K/Akt) and Stat5 (activated by BCR-ABL) as additional direct regulators, establishing a rich transcriptional control logic linking LCN2 to inflammatory, survival, and oncogenic signaling.\",\n      \"evidence\": \"Promoter deletion/reporter assays for NF-κB/C/EBP; ChIP for Foxo3a and Stat5 binding; epistasis with constitutively active Akt and BCR-ABL pathway inhibitors\",\n      \"pmids\": [\"16798734\", \"19056725\", \"19229297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of each transcription factor in different tissues were not quantified\", \"Chromatin-level regulation (enhancers, epigenetic marks) was not addressed\", \"Post-transcriptional regulation of LCN2 mRNA was unexplored\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"NGAL-deficient mice demonstrated that siderophore sequestration confers bacteriostatic innate immunity, while LPS/TLR4 signaling was shown to induce LCN2 via NF-κB in macrophages and C/EBP in epithelial cells, linking pathogen sensing to LCN2 expression.\",\n      \"evidence\": \"NGAL-KO mice with increased bacterial growth; TLR4-mutant (C3H/HeJ) mice with abrogated LCN2 induction; EMSA for NF-κB and C/EBP\",\n      \"pmids\": [\"17229907\", \"17490638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of siderophore-independent mechanisms to host defense was not dissected\", \"Whether LCN2 targets specific bacterial species preferentially was unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"LCN2 was shown to promote epithelial-to-mesenchymal transition in breast cancer by suppressing ERα and inducing Slug, establishing a pro-metastatic role verified by increased invasion and lymph node metastasis in orthotopic models.\",\n      \"evidence\": \"LCN2 overexpression/silencing with EMT marker analysis, ERα rescue, orthotopic mouse model\",\n      \"pmids\": [\"19237579\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether iron-binding status affects EMT promotion was not tested\", \"Relevance to non-breast cancer EMT was not established\", \"Direct versus indirect mechanism of ERα suppression was unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"24p3-null mice revealed that LCN2-mediated Bim induction is required for normal apoptotic turnover across multiple hematopoietic lineages, confirming in vivo the iron-efflux/Bim axis as a broad physiological cell-death mechanism rather than an in vitro artifact.\",\n      \"evidence\": \"24p3-KO mice in two backgrounds with apoptosis assays across neutrophils, mast cells, thymocytes, and erythroid cells; competitive repopulation\",\n      \"pmids\": [\"21507940\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether 24p3R is the sole receptor mediating this effect in vivo was not formally tested\", \"Mechanism linking iron depletion to Bim transcription was not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"24p3-deficient neutrophils showed impaired chemotaxis, extravasation, and phagocytosis via cytoskeletal gene suppression and microRNA upregulation, revealing a siderophore-independent function of LCN2 in innate immune cell motility.\",\n      \"evidence\": \"24p3-KO mice with Listeria/Candida/Staphylococcus infection, neutrophil functional assays, transcriptome and microRNA profiling\",\n      \"pmids\": [\"23543755\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which microRNAs are directly regulated by LCN2 was not established\", \"Whether the cytoskeletal effect is iron-dependent was untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"LCN2 was shown to regulate hepatic lipid droplet formation through control of PLIN5 expression, extending its metabolic roles beyond iron trafficking.\",\n      \"evidence\": \"Lcn2-KO mice on MCD/high-fat diets, adenoviral LCN2 reconstitution restoring PLIN5 and lipid droplets\",\n      \"pmids\": [\"25086218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LCN2 regulates PLIN5 transcriptionally or post-transcriptionally was not defined\", \"Iron dependence of this lipid-metabolism function was not assessed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"LCN2 was found to suppress protective autophagy in cardiomyocytes during ischemia by inhibiting AMPK/ULK1 signaling and lysosomal function, thereby exacerbating cytochrome c release and apoptosis—a mechanism distinct from its canonical iron-efflux apoptosis pathway.\",\n      \"evidence\": \"Lcn2-KO mice with coronary ligation, multiple autophagy readouts (LC3, p62, TEM, tandem LC3 assay), DN-Atg5 epistasis\",\n      \"pmids\": [\"27800610\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How LCN2 inhibits AMPK mechanistically was not resolved\", \"Whether this autophagy-suppressive function occurs in other tissues was unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"LCN2 was established as a key ferroptosis regulator: NF-κB-driven LCN2 upregulation sequesters iron to confer ferroptosis resistance in hepatocellular carcinoma, while LCN2-neutralizing antibody sensitizes tumors to sorafenib, opening a therapeutic axis.\",\n      \"evidence\": \"Hepatocyte-specific Lifr-KO mice, NF-κB pathway analysis, ferroptosis assays, LCN2-neutralizing antibody in PDX model\",\n      \"pmids\": [\"34921145\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LCN2-mediated ferroptosis resistance generalizes beyond HCC was not shown\", \"The siderophore identity mediating iron sequestration in cancer was unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Astrocytic LCN2 was identified as a neuroinflammatory mediator: NHE1–NOX–NF-κB signaling drives LCN2 secretion in exosomes from reactive astrocytes, which induce neuronal death after stroke, establishing a paracrine neurotoxic mechanism.\",\n      \"evidence\": \"Astrocyte-specific Nhe1-KO mice in stroke model, exosome isolation, NOX/NF-κB inhibitors, neuronal viability assays\",\n      \"pmids\": [\"35440572\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LCN2 is the sole neurotoxic cargo in astrocytic exosomes was not determined\", \"Neuronal receptor mediating exosome-delivered LCN2 toxicity was not identified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Multiple 2023 studies expanded the ferroptosis/cancer axis: tissue-infiltrating neutrophils were identified as the primary LCN2 source driving ferroptosis-mediated cachexia, LCN2 was shown to bind SLC3A2 to inhibit GSH/GPX4, and LCN2 was found to bind EGFR and enhance its recycling to activate MEK-ERK signaling in oral cancer, while a MafG/MYH9 complex was identified as a novel transcriptional activator via MARE motifs in the LCN2 promoter conferring hepatic stellate cell ferroptosis resistance.\",\n      \"evidence\": \"Myeloid-specific Lcn2-KO and neutrophil depletion in cachexia models; co-IP of LCN2–SLC3A2; MS-identified LCN2–EGFR interaction with recycling assays and PDX validation; co-IP of MafG–MYH9 with MARE mutagenesis and LCN2 reconstitution in HSCs\",\n      \"pmids\": [\"36973755\", \"37130481\", \"36899380\", \"38871948\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LCN2–SLC3A2 interaction is direct or requires iron/siderophore was not established\", \"EGFR recycling mechanism (trafficking machinery) was not defined\", \"MafG/MYH9 role in non-hepatic LCN2 regulation was not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Proteasome inhibition (stabilizing IκBα to suppress NF-κB) and mTOR inhibition (activating autophagic degradation of LCN2) were identified as two mechanistically distinct strategies to reduce astrocytic LCN2 secretion, with the N-terminal signal peptide required for both secretion and pre-secretory autophagic targeting.\",\n      \"evidence\": \"LPS-stimulated primary astrocytes with bortezomib and mTOR inhibitor, signal peptide deletion mutants, autophagy flux assays, neuronal viability\",\n      \"pmids\": [\"36781380\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether signal peptide-mediated autophagic targeting is unique to LCN2 or generalizable was unknown\", \"In vivo validation of these suppressive strategies was not provided\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Two epigenetic/post-translational regulatory layers were defined: H3K9 β-hydroxybutyrylation at the LCN2 promoter activates transcription (repressed by BDH1-mediated ketone rebalancing), and FBXO2 targets LCN2 for K27-linked polyubiquitination and proteasomal degradation, revealing that LCN2 protein levels are tightly controlled by both chromatin and ubiquitin-proteasome pathways.\",\n      \"evidence\": \"ChIP for H3K9bhb at LCN2 promoter with BDH1-KO/OE and A485 inhibitor; FBXO2–LCN2 co-IP with FBA domain mapping, K27-linkage ubiquitination assay, proteasome inhibitor rescue, FBXO2-KO mice\",\n      \"pmids\": [\"40022118\", \"40791152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which lysine residues on LCN2 are K27-ubiquitinated was not mapped\", \"Whether H3K9bhb regulation of LCN2 occurs in non-cardiac tissues was not tested\", \"Interplay between ubiquitination and autophagic degradation of LCN2 was not examined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Post-transcriptional stabilization of LCN2 mRNA by the vault protein MVP (dephosphorylated at S873 by PGAM5) was identified as a mechanism of ferroptosis resistance and sorafenib resistance in HCC, with tenapanor disrupting the MVP–LCN2 mRNA interaction.\",\n      \"evidence\": \"RBP screening, MVP–LCN2 mRNA binding and stability assays, PGAM5 dephosphorylation at S873, tenapanor treatment in HCC cells and in vivo\",\n      \"pmids\": [\"40262414\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The RNA element in LCN2 mRNA recognized by MVP was not mapped\", \"Independent replication of MVP–LCN2 mRNA axis is needed\", \"Whether this mechanism operates outside HCC was not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of endogenous mammalian siderophores that bind LCN2 remains poorly characterized, the structural basis of LCN2's siderophore-independent functions (cytoskeletal regulation, autophagy suppression, EGFR recycling) is largely undefined, and the relative contributions of 24p3R versus megalin in different tissues and disease contexts have not been systematically resolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Endogenous mammalian siderophore identity remains elusive\", \"Structural mechanism for LCN2–EGFR and LCN2–SLC3A2 interactions not resolved at atomic level\", \"Tissue-specific receptor usage (24p3R vs. megalin) not systematically mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 1, 5, 7, 35]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [5, 6, 7, 21]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [7, 22, 26]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [20, 22, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 3, 5, 7, 21, 23, 26]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [23, 24]},\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 7, 8, 11, 16, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 10, 13, 15, 22, 28, 32]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3, 6, 14, 20, 22, 26]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5, 6, 18, 21]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [10, 12, 22, 26, 34]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [20, 25]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [30]}\n    ],\n    \"complexes\": [\n      \"NGAL-MMP9\",\n      \"LCN2-LOXL2-MMP9\"\n    ],\n    \"partners\": [\n      \"MMP9\",\n      \"SLC22A17\",\n      \"LRP2\",\n      \"EGFR\",\n      \"FBXO2\",\n      \"LOXL2\",\n      \"SLC3A2\",\n      \"MVP\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}